mr KENNETH HERTZ

Responded to inquiry regarding in-home supportive services programs. S. 1549, Care Planning Act - Discussed the bill and urged cosponsorship. Discussed structural changes to Medicaid. Discussed health care quality and measurement. Discussed changes to the Medicare benefit design, such as copays, premiums and deductibles. H.R.1571, Improving Access to Medicare Coverage Act - Discussed bill. S.578, Home Health Planning Improvement Act - Discussed bill and urged cosponsorship. Discussed the Medicare Part D prescription drug benefit program and changes needed to lower prescription drug costs and related agency proposed rule changes. S. 1083, H.R.2005 - Discussed legislation to require drug manufacturers to provide rebates for drugs provided to Medicare Part D low-income subsidy beneficiaries, including those who are dually eligible for Medicare and Medicaid. S. 1488, H.R. 2624, Part D Beneficiary Appeals Fairness Act - Discussed bill that would allow seniors to appeal the placement of their medications on a Medicare Part D specialty tier. Discussed Medicare Part D fraud and abuse legislation including lock-in provisions for high risk enrollees. Discussed legislation to require the addition of unique device identifier (UDI) of medical devices in health insurance claim forms. Discussed the Medicare Part B prescription drug demonstration proposal from the Centers for Medicare and Medicaid Services. S. 624, H.R.1220,Removing Barriers to Colorectal Cancer Screening Act - Discussed bill. S. 3040, Labor, Health and Human Services,FY2017 - Lobbied in support of increased funding for CMS' state survey and certification program. S. 1549 - Discussed support of Care Planning Act. Discussed the Medicare Part B prescription drug benefit program and changes needed to lower prescription drug costs and related agency proposed rule changes. H.R. 5122 - Discussed the Medicare Part B prescription drug demonstration proposal. Discussed potential benefit and coverage improvements under Medicare and Medicaid Savings Programs. H.R. 2759, Mental Health Access Improvement Act - Discussed support of bill. Discussed MACRA implementation. Discussed Medicare enrollment and coverage issues such as: provider access, direct billing and penalties. S. 1719, H.R. 3099, RAISE Act - Discussed CMS' efforts regarding family caregiving. Provided feedback on advanced directive registry bill. (no bill #) Discussed independence at home legislation. S. 2961, Compassionate Care Act - Discussed our position and provided feedback. Discussed DOJ investigation regarding Olmstead and ADA violations by South Dakota and provided feedback (DOJ). Responded to inquiry regarding roundtable (ACL). S. 3096, Removing Barriers to Person-Centered Care Act of 2016 - Discussed and provided feedback. Discussed possible hearing witnesses. Discussed Medicaid HCBS spousal impoverishment bill. (no bill #) Responded to inquiry regarding MACRA rules and value modifier. Discussed Medicare's 180-day coverage of skilled nursing facility care. S. 2836, H.R. 5036, Protecting Families with Disabilities Act - Signed letter in support of bill.

H.R. 1270, S.709, Restoring Access to Medication Act - Meetings, calls and emails urging support. H.R. 3590 - Halt Tax Increases on the Middle Class and Seniors Act - Meetings, calls and emails urging support. Lobbied the Centers for Medicare and Medicaid Services on the 2017 Medicare Advantage Advance Notice and Medicare Part D Call Letter. Discussed the Fair Medical Billing Act. (no bill #) Discussed Medicare Advantage, Medicare Supplemental and employer health insurance. Discussed Global Council on Brain Health, brain health generally and Alzheimer's. (no bill #) S. 192, Older Americans Act - Discussed reauthorization and urged congressional offices to sign letter of support. Discussed Affordable Care Act Medicaid expansion issues, including AARP comments on state 1115 waiver proposals to expand Medicaid. Discussed Medicare-Medicaid integration efforts and financial alignment demonstrations, other CMS demonstration initiatives. (no bill #) Discussed Older Americans Act home and community-based services program funding for FY2017. Discussed nutrition programs including the Supplemental Nutrition Assistance Program (SNAP)and related changes under the 2014 farm bill. H.R.1220, S.624, Removing Barriers to Colorectal Cancer Screening Act - Discussed bill. Labor, Health and Human Services Appropriations, FY2017 - Lobbied for funding support for various health and health care related programs serving seniors. (no bill #)

S. 709, H.R. 1270,Restoring Access to Medication Act - Meetings, calls and emails urging support. H.R. 3590 - Halt Tax Increases on the Middle Class and Seniors Act - Meetings, calls and emails urging support. Discussed the Fair Medical Billing Act. (no bill #) Discussed Medicare Advantage, Medicare Supplemental and employer health insurance. S. 192, Older Americans Act - Discussed reauthorization. Discussed Affordable Care Act Medicaid expansion issues, including AARP comments on state 1115 waiver proposals to expand Medicaid. Discussed Medicare-Medicaid integration efforts and financial alignment demonstrations, other CMS demonstration initiatives. Discussed Older Americans Act home and community-based services program funding for FY2017. S. 2956, H.R. 5054 - Discussed nutrition programs including the Supplemental Nutrition Assistance Program (SNAP)and related changes under the 2014 farm bill. S. 624, H.R.1220, Removing Barriers to Colorectal Cancer Screening Act - Discussed bill. S. 3040, Labor, Health and Human Services Appropriations, FY2017 - Lobbied for funding support for various health and health care related programs serving seniors. (no bill #) S.311, Seniors Tax Hike Prevention Act - Discussed medical expense deduction for the 65 plus population. Advocated on the issue of limited age rating for private health insurance. Advocated on the medical expense tax deduction. Shared comment letters on SNAP with Agriculture Committee staff.

S. 709, H.R. 1270, Restoring Access to Medication Act - Supported bill. H.R. 3590, Halt Tax Increases on the Middle Class and Seniors Act - Meetings, calls and emails urging support. Discussed the Fair Medical Billing Act. Discussed Medicare Advantage, Medicare Supplemental and employer health insurance. Discussed Affordable Care Act Medicaid expansion issues, including AARP comments on state 1115 waiver proposals to expand Medicaid. Discussed Medicare-Medicaid integration efforts and financial alignment demonstrations, other CMS demonstration initiatives. Discussed Older Americans Act home and community-based services program funding for FY2017. S. 2956, H.R. 5054 - Discussed nutrition programs including the Supplemental Nutrition Assistance Program (SNAP)and related changes under the 2014 farm bill. S. 3040, H.R. 5926, H.R. 5325, Labor, Health and Human Services Appropriations, FY2017 - Lobbied for funding support for various health and health care related programs serving seniors. S.3111, Seniors Tax Hike Prevention Act - Discussed medical expense deduction for the 65 plus population. Advocated on the issue of limited age rating for private health insurance. S. 3335, H.R. 6043, FAIR Drug Pricing Act - Supported bill.

S. 3040, H.R. 5926, H.R. 5325, H.R. 2028, Labor, Health and Human Services Appropriations bill, FY2017 - Lobbied in support of increased funding for CMS' state survey and certification program. Discussed Medicaid per capita caps and block grants. Discussed DOJ investigation regarding findings of Olmstead and ADA violations by South Dakota. Discussed Olmstead and older adults roundtable and next steps (Administration for Community Living). Discussed arbitration provision in long-term care facility requirements final rule and related issues (no bill, Senate) and discussed final rule in general (CMS webinar). Provided information regarding Medicaid managed long-term services and supports and discussed family caregiver assessment in Medicaid home and community-based services. Discussed impending nursing home closure and resident relocation in the Virgin Islands and related issues. Discussed extension of the Money Follows the Person Rebalancing Demonstration Program. Discussed long-term services and supports financing, Social Security Caregiver Credit Act of 2015 (H.R. 3377), and family caregiving. S. 3504, Creating High-Quality Results and Outcomes Necessary to Improve Chronic (CHRONIC) Care Act - Discussed and provided feedback on draft bill. PL 113-185, Participated in CMS call on the Improving Medicare Post-Acute Care Transformation (IMPACT) Act of 2014. Discussed caregiver-focused health risk assessment in Medicare physician fee schedule final rule. Discussed AARP statement on Medicare physician fee schedule. S. 843, H.R. 1571, Improving Access to Medicare Coverage Act of 2015 - Discussed bill. Discussed health care quality and measurement. Discussed changes to the Medicare benefit design, such as copays, premiums, and deductibles. Discussed MACRA implementation. P.L. 111-148, P.L. 111-152 - Discussed potential repeal of Affordable Care Act. S. 9 - Sent endorsement letter for the Over the Counter Hearing Aid Act of 2016.

Responded to inquiry regarding in-home supportive services programs. S. 1549, Care Planning Act - Discussed the bill and urged cosponsorship. Discussed structural changes to Medicaid. Discussed health care quality and measurement. Discussed changes to the Medicare benefit design, such as copays, premiums and deductibles. H.R.1571, Improving Access to Medicare Coverage Act - Discussed bill. S.578, Home Health Planning Improvement Act - Discussed bill and urged cosponsorship. Discussed the Medicare Part D prescription drug benefit program and changes needed to lower prescription drug costs and related agency proposed rule changes. S. 1083, H.R.2005 - Discussed legislation to require drug manufacturers to provide rebates for drugs provided to Medicare Part D low-income subsidy beneficiaries, including those who are dually eligible for Medicare and Medicaid. S. 1488, H.R. 2624, Part D Beneficiary Appeals Fairness Act - Discussed bill that would allow seniors to appeal the placement of their medications on a Medicare Part D specialty tier. Discussed Medicare Part D fraud and abuse legislation including lock-in provisions for high risk enrollees. Discussed legislation to require the addition of unique device identifier (UDI) of medical devices in health insurance claim forms. Discussed the Medicare Part B prescription drug demonstration proposal from the Centers for Medicare and Medicaid Services. S. 624, H.R.1220,Removing Barriers to Colorectal Cancer Screening Act - Discussed bill. S. 3040, Labor, Health and Human Services,FY2017 - Lobbied in support of increased funding for CMS' state survey and certification program. S. 1549 - Discussed support of Care Planning Act. Discussed the Medicare Part B prescription drug benefit program and changes needed to lower prescription drug costs and related agency proposed rule changes. H.R. 5122 - Discussed the Medicare Part B prescription drug demonstration proposal. Discussed potential benefit and coverage improvements under Medicare and Medicaid Savings Programs. H.R. 2759, Mental Health Access Improvement Act - Discussed support of bill. Discussed MACRA implementation. Discussed Medicare enrollment and coverage issues such as: provider access, direct billing and penalties. S. 1719, H.R. 3099, RAISE Act - Discussed CMS' efforts regarding family caregiving. Provided feedback on advanced directive registry bill. (no bill #) Discussed independence at home legislation. S. 2961, Compassionate Care Act - Discussed our position and provided feedback. Discussed DOJ investigation regarding Olmstead and ADA violations by South Dakota and provided feedback (DOJ). Responded to inquiry regarding roundtable (ACL). S. 3096, Removing Barriers to Person-Centered Care Act of 2016 - Discussed and provided feedback. Discussed possible hearing witnesses. Discussed Medicaid HCBS spousal impoverishment bill. (no bill #) Responded to inquiry regarding MACRA rules and value modifier. Discussed Medicare's 180-day coverage of skilled nursing facility care. S. 2836, H.R. 5036, Protecting Families with Disabilities Act - Signed letter in support of bill.

Responded to inquiry regarding in-home supportive services programs. (no bill #) S. 1549, Care Planning Act - Discussed the bill and urged cosponsorship. Discussed structural changes to Medicaid. (no bill #) Discussed health care quality and measurement. (no bill #) Discussed changes to the Medicare benefit design, such as copays, premiums and deductibles. (no bill #) Discussed Personalize Your Care Act and provided feedback. (no bill #) Discussed Money Follows the Person Rebalancing Demonstration. (no bill #) Made inquiry regarding DC Medicaid HCBS waiver. (no bill #) S. 1085, Military and Veteran Caregiver Services Improvement Act - Discussed bill. H.R. 4878, Better Care Lower Cost Act - Discussed bill. Discussed spousal impoverishment in Medicaid. (no bill #) H.R. 4059, S.2297, Medicare Choices Empowerment and Protection Act - Provided feedback on bill. H.R. 3298, Medicare Post-Acute Care Value-Based Purchasing Act - Discussed feedback and next steps. (no bill #) Inquired regarding final rule on discharge planning. (no bill #) H.R.1571, Improving Access to Medicare Coverage Act - Discussed bill. Discussed retroactive eligibility for Medicaid HCBS (no bill #) Discussed observations status issues. (no bill #) S.578, Home Health Planning Improvement Act - Discussed bill and urged cosponsorship. Discussed the Medicare Part D prescription drug benefit program and changes needed to lower prescription drug costs and related agency proposed rule changes. (no bill #) H.R.2005, S.1083 - Discussed legislation to require drug manufacturers to provide rebates for drugs provided to Medicare Part D low-income subsidy beneficiaries, including those who are dually eligible for Medicare and Medicaid. H.R. 2624, S.1488, Part D Beneficiary Appeals Fairness Act- Discussed bill that would allow seniors to appeal the placement of their medications on a Medicare Part D specialty tier. Discussed Medicare Part D fraud and abuse legislation including lock-in provisions for high risk enrollees. (no bill #) Discussed legislation to require the addition of unique device identifier (UDI) of medical devices in health insurance claim forms. Discussed the Medicare Part B prescription drug demonstration proposal from the Centers for Medicare and Medicaid Services. H.R.1220, S.624, Removing Barriers to Colorectal Cancer Screening Act - Discussed bill. Discussed Medicare site of service payment policy. (no bill #) H.R. 4442,S.2484,CONNECT Act - Sent letter of endorsement. Discussed Medicare coverage and reimbursement of cataract surgery. Labor, Health and Human Services,FY2017 - Lobbied in support of increased funding for CMS' state survey and certification program. (no bill #)

Discussed structural changes to Medicaid. Discussed health care quality and measurement. Discussed changes to the Medicare benefit design, such as copays, premiums and deductibles. S. 1083, H.R.2005 - Discussed legislation to require drug manufacturers to provide rebates for drugs provided to Medicare Part D low-income subsidy beneficiaries, including those who are dually eligible for Medicare and Medicaid. S. 1488, H.R. 2624, Part D Beneficiary Appeals Fairness Act - Discussed bill that would allow seniors to appeal the placement of their medications on a Medicare Part D specialty tier. Discussed Medicare Part D fraud and abuse legislation including lock-in provisions for high risk enrollees. Discussed legislation to require the addition of unique device identifier (UDI) of medical devices in health insurance claim forms. S. 624, H.R.1220, Removing Barriers to Colorectal Cancer Screening Act - Discussed bill. S. 3040, H.R. 5926, H.R. 5325, Labor, Health and Human Services Appropriations bill, FY2017 - Lobbied in support of increased funding for CMS' state survey and certification program. Discussed the Medicare Part D prescription drug benefit program and changes needed to lower prescription drug costs and related agency proposed rule changes. H.R. 5122 - Discussed the Medicare Part B prescription drug demonstration proposal from the Centers for Medicare and Medicaid Services. Discussed potential benefit and coverage improvements under Medicare and Medicare Savings Programs. Discussed Section 1115 Medicaid expansion demonstration waivers (HHS, CMS). H.R. 2759, Mental Health Access Improvement Act - Discussed support of bill. Discussed MACRA implementation. Discussed Medicare enrollment and coverage issues such as: provider access, direct billing and penalties. Discussed DOJ investigation regarding Olmstead and ADA violations by South Dakota (DOJ, ACL) and related public events. Discussed Olmstead enforcement and older adults at roundtable discussion. S. 3096, Removing Barriers to Person-Centered Care Act of 2016 - Discussed and provided feedback. Discussed possible hearing witnesses. Responded to inquiry regarding MACRA rules and value modifier. H.R. 3298, Post Acute Care Value Based Purchasing Act - Discussed and provided feedback. Discussed arbitration provision in LTC facility requirements proposed rule (OMB, CMS, HHS). Responded to inquiry on Virtual Caregiving Fair. PL 111-148 - Discussed ACA Medicaid HCBS spousal impoverishment provisions. Responded to inquiry on state nursing home legislation. Discussed Medicaid assisted living, HCBS setting rule and follow-up (GAO). Discussed Medicare home health (CMS). Urged support for family caregivers in Medicare and Medicaid and testing modeling. Signed letter to CMS regarding arbitration in LTC facility requirements rule. Discussed family caregiver assessment guidance (CMS). Attended PPI home health roundtable with staff from HHS. Responded to a question about a scorecard and letters to CMS. Responded to an inquiry regarding an arbitration regulatory provision. Responded to an inquiry regarding personal needs allowances. Discussed Medicaid functional assessment tools, family caregiver assessment, and follow-up(GAO). Responded to inquiries regarding Medicaid managed long-term services and supports, best practices, and state ombuds programs. S. 3130, Independence at Home Act - Discussed and sent AARP endorsement letter for bill

Responded to inquiry regarding in-home supportive services programs. (no bill #) S. 1549, Care Planning Act - Discussed the bill and urged cosponsorship. Discussed structural changes to Medicaid. (no bill #) Discussed health care quality and measurement. (no bill #) Discussed changes to the Medicare benefit design, such as copays, premiums and deductibles. (no bill #) Discussed Personalize Your Care Act and provided feedback. (no bill #) Discussed Money Follows the Person Rebalancing Demonstration. (no bill #) Made inquiry regarding DC Medicaid HCBS waiver. (no bill #) S. 1085, Military and Veteran Caregiver Services Improvement Act - Discussed bill. H.R. 4878, Better Care Lower Cost Act - Discussed bill. Discussed spousal impoverishment in Medicaid. (no bill #) H.R. 4059, S.2297, Medicare Choices Empowerment and Protection Act - Provided feedback on bill. H.R. 3298, Medicare Post-Acute Care Value-Based Purchasing Act - Discussed feedback and next steps. (no bill #) Inquired regarding final rule on discharge planning. (no bill #) H.R.1571, Improving Access to Medicare Coverage Act - Discussed bill. Discussed retroactive eligibility for Medicaid HCBS (no bill #) Discussed observations status issues. (no bill #) S.578, Home Health Planning Improvement Act - Discussed bill and urged cosponsorship. Discussed the Medicare Part D prescription drug benefit program and changes needed to lower prescription drug costs and related agency proposed rule changes. (no bill #) H.R.2005, S.1083 - Discussed legislation to require drug manufacturers to provide rebates for drugs provided to Medicare Part D low-income subsidy beneficiaries, including those who are dually eligible for Medicare and Medicaid. H.R. 2624, S.1488, Part D Beneficiary Appeals Fairness Act- Discussed bill that would allow seniors to appeal the placement of their medications on a Medicare Part D specialty tier. Discussed Medicare Part D fraud and abuse legislation including lock-in provisions for high risk enrollees. (no bill #) Discussed legislation to require the addition of unique device identifier (UDI) of medical devices in health insurance claim forms. Discussed the Medicare Part B prescription drug demonstration proposal from the Centers for Medicare and Medicaid Services. H.R.1220, S.624, Removing Barriers to Colorectal Cancer Screening Act - Discussed bill. Discussed Medicare site of service payment policy. (no bill #) H.R. 4442,S.2484,CONNECT Act - Sent letter of endorsement. Discussed Medicare coverage and reimbursement of cataract surgery. Labor, Health and Human Services,FY2017 - Lobbied in support of increased funding for CMS' state survey and certification program. (no bill #)

Responded to inquiry regarding in-home supportive services programs. S. 1549, Care Planning Act - Discussed the bill and urged cosponsorship. Discussed structural changes to Medicaid. Discussed health care quality and measurement. Discussed changes to the Medicare benefit design, such as copays, premiums and deductibles. H.R.1571, Improving Access to Medicare Coverage Act - Discussed bill. S.578, Home Health Planning Improvement Act - Discussed bill and urged cosponsorship. Discussed the Medicare Part D prescription drug benefit program and changes needed to lower prescription drug costs and related agency proposed rule changes. S. 1083, H.R.2005 - Discussed legislation to require drug manufacturers to provide rebates for drugs provided to Medicare Part D low-income subsidy beneficiaries, including those who are dually eligible for Medicare and Medicaid. S. 1488, H.R. 2624, Part D Beneficiary Appeals Fairness Act - Discussed bill that would allow seniors to appeal the placement of their medications on a Medicare Part D specialty tier. Discussed Medicare Part D fraud and abuse legislation including lock-in provisions for high risk enrollees. Discussed legislation to require the addition of unique device identifier (UDI) of medical devices in health insurance claim forms. Discussed the Medicare Part B prescription drug demonstration proposal from the Centers for Medicare and Medicaid Services. S. 624, H.R.1220,Removing Barriers to Colorectal Cancer Screening Act - Discussed bill. S. 3040, Labor, Health and Human Services,FY2017 - Lobbied in support of increased funding for CMS' state survey and certification program. S. 1549 - Discussed support of Care Planning Act. Discussed the Medicare Part B prescription drug benefit program and changes needed to lower prescription drug costs and related agency proposed rule changes. H.R. 5122 - Discussed the Medicare Part B prescription drug demonstration proposal. Discussed potential benefit and coverage improvements under Medicare and Medicaid Savings Programs. H.R. 2759, Mental Health Access Improvement Act - Discussed support of bill. Discussed MACRA implementation. Discussed Medicare enrollment and coverage issues such as: provider access, direct billing and penalties. S. 1719, H.R. 3099, RAISE Act - Discussed CMS' efforts regarding family caregiving. Provided feedback on advanced directive registry bill. (no bill #) Discussed independence at home legislation. S. 2961, Compassionate Care Act - Discussed our position and provided feedback. Discussed DOJ investigation regarding Olmstead and ADA violations by South Dakota and provided feedback (DOJ). Responded to inquiry regarding roundtable (ACL). S. 3096, Removing Barriers to Person-Centered Care Act of 2016 - Discussed and provided feedback. Discussed possible hearing witnesses. Discussed Medicaid HCBS spousal impoverishment bill. (no bill #) Responded to inquiry regarding MACRA rules and value modifier. Discussed Medicare's 180-day coverage of skilled nursing facility care. S. 2836, H.R. 5036, Protecting Families with Disabilities Act - Signed letter in support of bill.

H.R.6 - Discussed the House Energy and Commerce Committee 21st Century Cures Initiative and Senate HELP Committee efforts focused on drug and medical device innovation issues. S. 31, H.R. 3061 - Discussed the importance of potential savings to both consumers and the federal government of granting Secretarial negotiating authority to the HHS Secretary under Medicare Part D. S. 2019 - Discussed legislation to address pay-for-delay agreements used by drug manufacturers to block lower cost drugs from entering the market. S. 3094, H.R. 5573 - Discussed legislation to reduce the market exclusivity period for biologic drugs. Discussed biologic drug issues including implementation of the new approval pathway for biosimilar drugs. S. 3335, H.R. 6043 - Discussed the need for price transparency on prescription drug prices and comparativeness effectiveness research. Discussed legislation to address the opioid abuse epidemic including fraud and abuse provisions. Discussed opioid issues generally. S. 3056 - Discussed legislation to address abuse of Risk-Evaluation and Mitigation Strategies (REMS) by brand name drug companies to block lower-cost generic drugs from entering the market. S. 3455 - Discussed legislation to allow temporary importation authority in cases of drug shortages and non-competitive markets. S. 2956, H.R. 5054, H.R. 5325, H.R. 2028, Agriculture Appropriations, FY2017 - Lobbied in support of FDA funding. H.R. 6043, FAIR Drug Pricing Act - Supported bill to require manufactures of certain drugs and biological products to report to HHS price increases that result in a 10% or more increase in the price of a drug over a 12 month period.

S. 3040, H.R. 5926, H.R. 5325, H.R. 2028, Labor, Health and Human Services Appropriations bill, FY2017 - Lobbied in support of increased funding for CMS' state survey and certification program. Discussed Medicaid per capita caps and block grants. Discussed DOJ investigation regarding findings of Olmstead and ADA violations by South Dakota. Discussed Olmstead and older adults roundtable and next steps (Administration for Community Living). Discussed arbitration provision in long-term care facility requirements final rule and related issues (no bill, Senate) and discussed final rule in general (CMS webinar). Provided information regarding Medicaid managed long-term services and supports and discussed family caregiver assessment in Medicaid home and community-based services. Discussed impending nursing home closure and resident relocation in the Virgin Islands and related issues. Discussed extension of the Money Follows the Person Rebalancing Demonstration Program. Discussed long-term services and supports financing, Social Security Caregiver Credit Act of 2015 (H.R. 3377), and family caregiving. S. 3504, Creating High-Quality Results and Outcomes Necessary to Improve Chronic (CHRONIC) Care Act - Discussed and provided feedback on draft bill. PL 113-185, Participated in CMS call on the Improving Medicare Post-Acute Care Transformation (IMPACT) Act of 2014. Discussed caregiver-focused health risk assessment in Medicare physician fee schedule final rule. Discussed AARP statement on Medicare physician fee schedule. S. 843, H.R. 1571, Improving Access to Medicare Coverage Act of 2015 - Discussed bill. Discussed health care quality and measurement. Discussed changes to the Medicare benefit design, such as copays, premiums, and deductibles. Discussed MACRA implementation. P.L. 111-148, P.L. 111-152 - Discussed potential repeal of Affordable Care Act. S. 9 - Sent endorsement letter for the Over the Counter Hearing Aid Act of 2016.

S. 3040, H.R. 5926, H.R. 5325,H.R. 2028, Labor, Health and Human Services Appropriations, FY2017 - Lobbied for funding support for various health and health care related programs serving seniors. S.3111, Seniors Tax Hike Prevention Act - Discussed medical expense deduction for the 65 plus population. Advocated on the issue of limited age rating for private health insurance. S. 3335, H.R. 6043, FAIR Drug Pricing Act - Supported bill. Discussed the Confidence in Long-Term Care Insurance Act (S. 159)/Long-Term Care Insurance Reform Act (H.R. 63) (bill numbers are in the 112th Congress). Discussed ACA repeal, Medicare, and Medicaid.

Responded to inquiry regarding in-home supportive services programs. (no bill #) S. 1549, Care Planning Act - Discussed the bill and urged cosponsorship. Discussed structural changes to Medicaid. (no bill #) Discussed health care quality and measurement. (no bill #) Discussed changes to the Medicare benefit design, such as copays, premiums and deductibles. (no bill #) Discussed Personalize Your Care Act and provided feedback. (no bill #) Discussed Money Follows the Person Rebalancing Demonstration. (no bill #) Made inquiry regarding DC Medicaid HCBS waiver. (no bill #) S. 1085, Military and Veteran Caregiver Services Improvement Act - Discussed bill. H.R. 4878, Better Care Lower Cost Act - Discussed bill. Discussed spousal impoverishment in Medicaid. (no bill #) H.R. 4059, S.2297, Medicare Choices Empowerment and Protection Act - Provided feedback on bill. H.R. 3298, Medicare Post-Acute Care Value-Based Purchasing Act - Discussed feedback and next steps. (no bill #) Inquired regarding final rule on discharge planning. (no bill #) H.R.1571, Improving Access to Medicare Coverage Act - Discussed bill. Discussed retroactive eligibility for Medicaid HCBS (no bill #) Discussed observations status issues. (no bill #) S.578, Home Health Planning Improvement Act - Discussed bill and urged cosponsorship. Discussed the Medicare Part D prescription drug benefit program and changes needed to lower prescription drug costs and related agency proposed rule changes. (no bill #) H.R.2005, S.1083 - Discussed legislation to require drug manufacturers to provide rebates for drugs provided to Medicare Part D low-income subsidy beneficiaries, including those who are dually eligible for Medicare and Medicaid. H.R. 2624, S.1488, Part D Beneficiary Appeals Fairness Act- Discussed bill that would allow seniors to appeal the placement of their medications on a Medicare Part D specialty tier. Discussed Medicare Part D fraud and abuse legislation including lock-in provisions for high risk enrollees. (no bill #) Discussed legislation to require the addition of unique device identifier (UDI) of medical devices in health insurance claim forms. Discussed the Medicare Part B prescription drug demonstration proposal from the Centers for Medicare and Medicaid Services. H.R.1220, S.624, Removing Barriers to Colorectal Cancer Screening Act - Discussed bill. Discussed Medicare site of service payment policy. (no bill #) H.R. 4442,S.2484,CONNECT Act - Sent letter of endorsement. Discussed Medicare coverage and reimbursement of cataract surgery. Labor, Health and Human Services,FY2017 - Lobbied in support of increased funding for CMS' state survey and certification program. (no bill #)

Discussed structural changes to Medicaid. Discussed health care quality and measurement. Discussed changes to the Medicare benefit design, such as copays, premiums and deductibles. S. 1083, H.R.2005 - Discussed legislation to require drug manufacturers to provide rebates for drugs provided to Medicare Part D low-income subsidy beneficiaries, including those who are dually eligible for Medicare and Medicaid. S. 1488, H.R. 2624, Part D Beneficiary Appeals Fairness Act - Discussed bill that would allow seniors to appeal the placement of their medications on a Medicare Part D specialty tier. Discussed Medicare Part D fraud and abuse legislation including lock-in provisions for high risk enrollees. Discussed legislation to require the addition of unique device identifier (UDI) of medical devices in health insurance claim forms. S. 624, H.R.1220, Removing Barriers to Colorectal Cancer Screening Act - Discussed bill. S. 3040, H.R. 5926, H.R. 5325, Labor, Health and Human Services Appropriations bill, FY2017 - Lobbied in support of increased funding for CMS' state survey and certification program. Discussed the Medicare Part D prescription drug benefit program and changes needed to lower prescription drug costs and related agency proposed rule changes. H.R. 5122 - Discussed the Medicare Part B prescription drug demonstration proposal from the Centers for Medicare and Medicaid Services. Discussed potential benefit and coverage improvements under Medicare and Medicare Savings Programs. Discussed Section 1115 Medicaid expansion demonstration waivers (HHS, CMS). H.R. 2759, Mental Health Access Improvement Act - Discussed support of bill. Discussed MACRA implementation. Discussed Medicare enrollment and coverage issues such as: provider access, direct billing and penalties. Discussed DOJ investigation regarding Olmstead and ADA violations by South Dakota (DOJ, ACL) and related public events. Discussed Olmstead enforcement and older adults at roundtable discussion. S. 3096, Removing Barriers to Person-Centered Care Act of 2016 - Discussed and provided feedback. Discussed possible hearing witnesses. Responded to inquiry regarding MACRA rules and value modifier. H.R. 3298, Post Acute Care Value Based Purchasing Act - Discussed and provided feedback. Discussed arbitration provision in LTC facility requirements proposed rule (OMB, CMS, HHS). Responded to inquiry on Virtual Caregiving Fair. PL 111-148 - Discussed ACA Medicaid HCBS spousal impoverishment provisions. Responded to inquiry on state nursing home legislation. Discussed Medicaid assisted living, HCBS setting rule and follow-up (GAO). Discussed Medicare home health (CMS). Urged support for family caregivers in Medicare and Medicaid and testing modeling. Signed letter to CMS regarding arbitration in LTC facility requirements rule. Discussed family caregiver assessment guidance (CMS). Attended PPI home health roundtable with staff from HHS. Responded to a question about a scorecard and letters to CMS. Responded to an inquiry regarding an arbitration regulatory provision. Responded to an inquiry regarding personal needs allowances. Discussed Medicaid functional assessment tools, family caregiver assessment, and follow-up(GAO). Responded to inquiries regarding Medicaid managed long-term services and supports, best practices, and state ombuds programs. S. 3130, Independence at Home Act - Discussed and sent AARP endorsement letter for bill

Responded to inquiry regarding in-home supportive services programs. S. 1549, Care Planning Act - Discussed the bill and urged cosponsorship. Discussed structural changes to Medicaid. Discussed health care quality and measurement. Discussed changes to the Medicare benefit design, such as copays, premiums and deductibles. H.R.1571, Improving Access to Medicare Coverage Act - Discussed bill. S.578, Home Health Planning Improvement Act - Discussed bill and urged cosponsorship. Discussed the Medicare Part D prescription drug benefit program and changes needed to lower prescription drug costs and related agency proposed rule changes. S. 1083, H.R.2005 - Discussed legislation to require drug manufacturers to provide rebates for drugs provided to Medicare Part D low-income subsidy beneficiaries, including those who are dually eligible for Medicare and Medicaid. S. 1488, H.R. 2624, Part D Beneficiary Appeals Fairness Act - Discussed bill that would allow seniors to appeal the placement of their medications on a Medicare Part D specialty tier. Discussed Medicare Part D fraud and abuse legislation including lock-in provisions for high risk enrollees. Discussed legislation to require the addition of unique device identifier (UDI) of medical devices in health insurance claim forms. Discussed the Medicare Part B prescription drug demonstration proposal from the Centers for Medicare and Medicaid Services. S. 624, H.R.1220,Removing Barriers to Colorectal Cancer Screening Act - Discussed bill. S. 3040, Labor, Health and Human Services,FY2017 - Lobbied in support of increased funding for CMS' state survey and certification program. S. 1549 - Discussed support of Care Planning Act. Discussed the Medicare Part B prescription drug benefit program and changes needed to lower prescription drug costs and related agency proposed rule changes. H.R. 5122 - Discussed the Medicare Part B prescription drug demonstration proposal. Discussed potential benefit and coverage improvements under Medicare and Medicaid Savings Programs. H.R. 2759, Mental Health Access Improvement Act - Discussed support of bill. Discussed MACRA implementation. Discussed Medicare enrollment and coverage issues such as: provider access, direct billing and penalties. S. 1719, H.R. 3099, RAISE Act - Discussed CMS' efforts regarding family caregiving. Provided feedback on advanced directive registry bill. (no bill #) Discussed independence at home legislation. S. 2961, Compassionate Care Act - Discussed our position and provided feedback. Discussed DOJ investigation regarding Olmstead and ADA violations by South Dakota and provided feedback (DOJ). Responded to inquiry regarding roundtable (ACL). S. 3096, Removing Barriers to Person-Centered Care Act of 2016 - Discussed and provided feedback. Discussed possible hearing witnesses. Discussed Medicaid HCBS spousal impoverishment bill. (no bill #) Responded to inquiry regarding MACRA rules and value modifier. Discussed Medicare's 180-day coverage of skilled nursing facility care. S. 2836, H.R. 5036, Protecting Families with Disabilities Act - Signed letter in support of bill.

Discussed structural changes to Medicaid. Discussed health care quality and measurement. Discussed changes to the Medicare benefit design, such as copays, premiums and deductibles. S. 1083, H.R.2005 - Discussed legislation to require drug manufacturers to provide rebates for drugs provided to Medicare Part D low-income subsidy beneficiaries, including those who are dually eligible for Medicare and Medicaid. S. 1488, H.R. 2624, Part D Beneficiary Appeals Fairness Act - Discussed bill that would allow seniors to appeal the placement of their medications on a Medicare Part D specialty tier. Discussed Medicare Part D fraud and abuse legislation including lock-in provisions for high risk enrollees. Discussed legislation to require the addition of unique device identifier (UDI) of medical devices in health insurance claim forms. S. 624, H.R.1220, Removing Barriers to Colorectal Cancer Screening Act - Discussed bill. S. 3040, H.R. 5926, H.R. 5325, Labor, Health and Human Services Appropriations bill, FY2017 - Lobbied in support of increased funding for CMS' state survey and certification program. Discussed the Medicare Part D prescription drug benefit program and changes needed to lower prescription drug costs and related agency proposed rule changes. H.R. 5122 - Discussed the Medicare Part B prescription drug demonstration proposal from the Centers for Medicare and Medicaid Services. Discussed potential benefit and coverage improvements under Medicare and Medicare Savings Programs. Discussed Section 1115 Medicaid expansion demonstration waivers (HHS, CMS). H.R. 2759, Mental Health Access Improvement Act - Discussed support of bill. Discussed MACRA implementation. Discussed Medicare enrollment and coverage issues such as: provider access, direct billing and penalties. Discussed DOJ investigation regarding Olmstead and ADA violations by South Dakota (DOJ, ACL) and related public events. Discussed Olmstead enforcement and older adults at roundtable discussion. S. 3096, Removing Barriers to Person-Centered Care Act of 2016 - Discussed and provided feedback. Discussed possible hearing witnesses. Responded to inquiry regarding MACRA rules and value modifier. H.R. 3298, Post Acute Care Value Based Purchasing Act - Discussed and provided feedback. Discussed arbitration provision in LTC facility requirements proposed rule (OMB, CMS, HHS). Responded to inquiry on Virtual Caregiving Fair. PL 111-148 - Discussed ACA Medicaid HCBS spousal impoverishment provisions. Responded to inquiry on state nursing home legislation. Discussed Medicaid assisted living, HCBS setting rule and follow-up (GAO). Discussed Medicare home health (CMS). Urged support for family caregivers in Medicare and Medicaid and testing modeling. Signed letter to CMS regarding arbitration in LTC facility requirements rule. Discussed family caregiver assessment guidance (CMS). Attended PPI home health roundtable with staff from HHS. Responded to a question about a scorecard and letters to CMS. Responded to an inquiry regarding an arbitration regulatory provision. Responded to an inquiry regarding personal needs allowances. Discussed Medicaid functional assessment tools, family caregiver assessment, and follow-up(GAO). Responded to inquiries regarding Medicaid managed long-term services and supports, best practices, and state ombuds programs. S. 3130, Independence at Home Act - Discussed and sent AARP endorsement letter for bill

Responded to inquiry regarding in-home supportive services programs. S. 1549, Care Planning Act - Discussed the bill and urged cosponsorship. Discussed structural changes to Medicaid. Discussed health care quality and measurement. Discussed changes to the Medicare benefit design, such as copays, premiums and deductibles. H.R.1571, Improving Access to Medicare Coverage Act - Discussed bill. S.578, Home Health Planning Improvement Act - Discussed bill and urged cosponsorship. Discussed the Medicare Part D prescription drug benefit program and changes needed to lower prescription drug costs and related agency proposed rule changes. S. 1083, H.R.2005 - Discussed legislation to require drug manufacturers to provide rebates for drugs provided to Medicare Part D low-income subsidy beneficiaries, including those who are dually eligible for Medicare and Medicaid. S. 1488, H.R. 2624, Part D Beneficiary Appeals Fairness Act - Discussed bill that would allow seniors to appeal the placement of their medications on a Medicare Part D specialty tier. Discussed Medicare Part D fraud and abuse legislation including lock-in provisions for high risk enrollees. Discussed legislation to require the addition of unique device identifier (UDI) of medical devices in health insurance claim forms. Discussed the Medicare Part B prescription drug demonstration proposal from the Centers for Medicare and Medicaid Services. S. 624, H.R.1220,Removing Barriers to Colorectal Cancer Screening Act - Discussed bill. S. 3040, Labor, Health and Human Services,FY2017 - Lobbied in support of increased funding for CMS' state survey and certification program. S. 1549 - Discussed support of Care Planning Act. Discussed the Medicare Part B prescription drug benefit program and changes needed to lower prescription drug costs and related agency proposed rule changes. H.R. 5122 - Discussed the Medicare Part B prescription drug demonstration proposal. Discussed potential benefit and coverage improvements under Medicare and Medicaid Savings Programs. H.R. 2759, Mental Health Access Improvement Act - Discussed support of bill. Discussed MACRA implementation. Discussed Medicare enrollment and coverage issues such as: provider access, direct billing and penalties. S. 1719, H.R. 3099, RAISE Act - Discussed CMS' efforts regarding family caregiving. Provided feedback on advanced directive registry bill. (no bill #) Discussed independence at home legislation. S. 2961, Compassionate Care Act - Discussed our position and provided feedback. Discussed DOJ investigation regarding Olmstead and ADA violations by South Dakota and provided feedback (DOJ). Responded to inquiry regarding roundtable (ACL). S. 3096, Removing Barriers to Person-Centered Care Act of 2016 - Discussed and provided feedback. Discussed possible hearing witnesses. Discussed Medicaid HCBS spousal impoverishment bill. (no bill #) Responded to inquiry regarding MACRA rules and value modifier. Discussed Medicare's 180-day coverage of skilled nursing facility care. S. 2836, H.R. 5036, Protecting Families with Disabilities Act - Signed letter in support of bill.

H.R.6 - Discussed the House Energy and Commerce Committee 21st Century Cures Initiative and Senate HELP Committee efforts focused on drug and medical device innovation issues. S. 31, H.R. 3061 - Discussed the importance of potential savings to both consumers and the federal government of granting Secretarial negotiating authority to the HHS Secretary under Medicare Part D. Discussed legislation to address pay-for-delay agreements used by drug manufacturers to block lower cost drugs from entering the market. S. 3094, H.R. 5573 - Discussed the exclusivity period for biologic drugs. Discussed biologic drug issues including implementation of the new approval pathway for biosimilar drugs. Discussed the need for price transparency on prescription drug prices and comparativeness effectiveness research. Discussed legislation to address the opioid abuse epidemic including fraud and abuse provisions. Discussed opioid issues generally. S. 3056 - Discussed legislation to address abuse of Risk-Evaluation and Mitigation Strategies (REMS) by brand name drug companies to block lower-cost generic drugs from entering the market. S. 1137, H.R. 9, Innovation Act, PATENT Act - Discussed patent reform legislation and related provisions on the Patent and Trademark Office inter partes review (IPR) process and proposed exemptions for brand name drug patents. S. 2956, H.R. 5054, Agriculture Appropriations, FY2017 - Lobbied in support of FDA funding. Responded to inquiry regarding Medicare Part B demonstration.

H.R.6 - Discussed the House Energy and Commerce Committee 21st Century Cures Initiative and Senate HELP Committee efforts focused on drug and medical device innovation issues. S. 31, H.R. 3061 - Discussed the importance of potential savings to both consumers and the federal government of granting Secretarial negotiating authority to the HHS Secretary under Medicare Part D. S. 2019 - Discussed legislation to address pay-for-delay agreements used by drug manufacturers to block lower cost drugs from entering the market. S. 3094, H.R. 5573 - Discussed legislation to reduce the market exclusivity period for biologic drugs. Discussed biologic drug issues including implementation of the new approval pathway for biosimilar drugs. S. 3335, H.R. 6043 - Discussed the need for price transparency on prescription drug prices and comparativeness effectiveness research. Discussed legislation to address the opioid abuse epidemic including fraud and abuse provisions. Discussed opioid issues generally. S. 3056 - Discussed legislation to address abuse of Risk-Evaluation and Mitigation Strategies (REMS) by brand name drug companies to block lower-cost generic drugs from entering the market. S. 3455 - Discussed legislation to allow temporary importation authority in cases of drug shortages and non-competitive markets. S. 2956, H.R. 5054, H.R. 5325, H.R. 2028, Agriculture Appropriations, FY2017 - Lobbied in support of FDA funding. H.R. 6043, FAIR Drug Pricing Act - Supported bill to require manufactures of certain drugs and biological products to report to HHS price increases that result in a 10% or more increase in the price of a drug over a 12 month period.

H.R.6 - Discussed the House Energy and Commerce Committee 21st Century Cures Initiative and Senate HELP Committee efforts focused on drug and medical device innovation issues. H.R. 3061, S. 31 - Discussed the importance of potential savings to both consumers and the federal government of granting Secretarial negotiating authority to the HHS Secretary under Medicare Part D. Discussed legislation to address pay-for-delay agreements used by drug manufacturers to block lower cost drugs from entering the market. Discussed the exclusivity period for biologic drugs. (no bill #) Discussed biologic drug issues including implementation of the new approval pathway for biosimilar drugs. Discussed other prescription drug issues and potential legislation on drug importation and least costly alternative payment for Part B drugs. (no bill #) Discussed the need for price transparency on prescription drug prices and comparativeness effectiveness research. Discussed legislation to address the opioid abuse epidemic including fraud and abuse provisions. Discussed opioid issues generally. (no bill #) H.R.9, S.1137 - Innovation Act, PATENT Act - Discussed patent reform legislation and related provisions on the Patent and Trademark Office inter partes review (IPR) process and proposed exemptions for brand name drug patents. Agriculture Appropriations, FY2017 - Lobbied in support of FDA funding. (no bill #)

H.R.6 - Discussed the House Energy and Commerce Committee 21st Century Cures Initiative and Senate HELP Committee efforts focused on drug and medical device innovation issues. S. 31, H.R. 3061 - Discussed the importance of potential savings to both consumers and the federal government of granting Secretarial negotiating authority to the HHS Secretary under Medicare Part D. S. 2019 - Discussed legislation to address pay-for-delay agreements used by drug manufacturers to block lower cost drugs from entering the market. S. 3094, H.R. 5573 - Discussed legislation to reduce the market exclusivity period for biologic drugs. Discussed biologic drug issues including implementation of the new approval pathway for biosimilar drugs. S. 3335, H.R. 6043 - Discussed the need for price transparency on prescription drug prices and comparativeness effectiveness research. Discussed legislation to address the opioid abuse epidemic including fraud and abuse provisions. Discussed opioid issues generally. S. 3056 - Discussed legislation to address abuse of Risk-Evaluation and Mitigation Strategies (REMS) by brand name drug companies to block lower-cost generic drugs from entering the market. S. 3455 - Discussed legislation to allow temporary importation authority in cases of drug shortages and non-competitive markets. S. 2956, H.R. 5054, H.R. 5325, Agriculture Appropriations, FY2017 - Lobbied in support of FDA funding. H.R. 6043, FAIR Drug Pricing Act - Supported bill to require manufactures of certain drugs and biological products to report to HHS price increases that result in a 10% or more increase in the price of a drug over a 12 month period.

Responded to inquiry regarding in-home supportive services programs. S. 1549, Care Planning Act - Discussed the bill and urged cosponsorship. Discussed structural changes to Medicaid. Discussed health care quality and measurement. Discussed changes to the Medicare benefit design, such as copays, premiums and deductibles. H.R.1571, Improving Access to Medicare Coverage Act - Discussed bill. S.578, Home Health Planning Improvement Act - Discussed bill and urged cosponsorship. Discussed the Medicare Part D prescription drug benefit program and changes needed to lower prescription drug costs and related agency proposed rule changes. S. 1083, H.R.2005 - Discussed legislation to require drug manufacturers to provide rebates for drugs provided to Medicare Part D low-income subsidy beneficiaries, including those who are dually eligible for Medicare and Medicaid. S. 1488, H.R. 2624, Part D Beneficiary Appeals Fairness Act - Discussed bill that would allow seniors to appeal the placement of their medications on a Medicare Part D specialty tier. Discussed Medicare Part D fraud and abuse legislation including lock-in provisions for high risk enrollees. Discussed legislation to require the addition of unique device identifier (UDI) of medical devices in health insurance claim forms. Discussed the Medicare Part B prescription drug demonstration proposal from the Centers for Medicare and Medicaid Services. S. 624, H.R.1220,Removing Barriers to Colorectal Cancer Screening Act - Discussed bill. S. 3040, Labor, Health and Human Services,FY2017 - Lobbied in support of increased funding for CMS' state survey and certification program. S. 1549 - Discussed support of Care Planning Act. Discussed the Medicare Part B prescription drug benefit program and changes needed to lower prescription drug costs and related agency proposed rule changes. H.R. 5122 - Discussed the Medicare Part B prescription drug demonstration proposal. Discussed potential benefit and coverage improvements under Medicare and Medicaid Savings Programs. H.R. 2759, Mental Health Access Improvement Act - Discussed support of bill. Discussed MACRA implementation. Discussed Medicare enrollment and coverage issues such as: provider access, direct billing and penalties. S. 1719, H.R. 3099, RAISE Act - Discussed CMS' efforts regarding family caregiving. Provided feedback on advanced directive registry bill. (no bill #) Discussed independence at home legislation. S. 2961, Compassionate Care Act - Discussed our position and provided feedback. Discussed DOJ investigation regarding Olmstead and ADA violations by South Dakota and provided feedback (DOJ). Responded to inquiry regarding roundtable (ACL). S. 3096, Removing Barriers to Person-Centered Care Act of 2016 - Discussed and provided feedback. Discussed possible hearing witnesses. Discussed Medicaid HCBS spousal impoverishment bill. (no bill #) Responded to inquiry regarding MACRA rules and value modifier. Discussed Medicare's 180-day coverage of skilled nursing facility care. S. 2836, H.R. 5036, Protecting Families with Disabilities Act - Signed letter in support of bill.

Responded to inquiry regarding in-home supportive services programs. (no bill #) S. 1549, Care Planning Act - Discussed the bill and urged cosponsorship. Discussed structural changes to Medicaid. (no bill #) Discussed health care quality and measurement. (no bill #) Discussed changes to the Medicare benefit design, such as copays, premiums and deductibles. (no bill #) Discussed Personalize Your Care Act and provided feedback. (no bill #) Discussed Money Follows the Person Rebalancing Demonstration. (no bill #) Made inquiry regarding DC Medicaid HCBS waiver. (no bill #) S. 1085, Military and Veteran Caregiver Services Improvement Act - Discussed bill. H.R. 4878, Better Care Lower Cost Act - Discussed bill. Discussed spousal impoverishment in Medicaid. (no bill #) H.R. 4059, S.2297, Medicare Choices Empowerment and Protection Act - Provided feedback on bill. H.R. 3298, Medicare Post-Acute Care Value-Based Purchasing Act - Discussed feedback and next steps. (no bill #) Inquired regarding final rule on discharge planning. (no bill #) H.R.1571, Improving Access to Medicare Coverage Act - Discussed bill. Discussed retroactive eligibility for Medicaid HCBS (no bill #) Discussed observations status issues. (no bill #) S.578, Home Health Planning Improvement Act - Discussed bill and urged cosponsorship. Discussed the Medicare Part D prescription drug benefit program and changes needed to lower prescription drug costs and related agency proposed rule changes. (no bill #) H.R.2005, S.1083 - Discussed legislation to require drug manufacturers to provide rebates for drugs provided to Medicare Part D low-income subsidy beneficiaries, including those who are dually eligible for Medicare and Medicaid. H.R. 2624, S.1488, Part D Beneficiary Appeals Fairness Act- Discussed bill that would allow seniors to appeal the placement of their medications on a Medicare Part D specialty tier. Discussed Medicare Part D fraud and abuse legislation including lock-in provisions for high risk enrollees. (no bill #) Discussed legislation to require the addition of unique device identifier (UDI) of medical devices in health insurance claim forms. Discussed the Medicare Part B prescription drug demonstration proposal from the Centers for Medicare and Medicaid Services. H.R.1220, S.624, Removing Barriers to Colorectal Cancer Screening Act - Discussed bill. Discussed Medicare site of service payment policy. (no bill #) H.R. 4442,S.2484,CONNECT Act - Sent letter of endorsement. Discussed Medicare coverage and reimbursement of cataract surgery. Labor, Health and Human Services,FY2017 - Lobbied in support of increased funding for CMS' state survey and certification program. (no bill #)

Discussed structural changes to Medicaid. Discussed health care quality and measurement. Discussed changes to the Medicare benefit design, such as copays, premiums and deductibles. S. 1083, H.R.2005 - Discussed legislation to require drug manufacturers to provide rebates for drugs provided to Medicare Part D low-income subsidy beneficiaries, including those who are dually eligible for Medicare and Medicaid. S. 1488, H.R. 2624, Part D Beneficiary Appeals Fairness Act - Discussed bill that would allow seniors to appeal the placement of their medications on a Medicare Part D specialty tier. Discussed Medicare Part D fraud and abuse legislation including lock-in provisions for high risk enrollees. Discussed legislation to require the addition of unique device identifier (UDI) of medical devices in health insurance claim forms. S. 624, H.R.1220, Removing Barriers to Colorectal Cancer Screening Act - Discussed bill. S. 3040, H.R. 5926, H.R. 5325, Labor, Health and Human Services Appropriations bill, FY2017 - Lobbied in support of increased funding for CMS' state survey and certification program. Discussed the Medicare Part D prescription drug benefit program and changes needed to lower prescription drug costs and related agency proposed rule changes. H.R. 5122 - Discussed the Medicare Part B prescription drug demonstration proposal from the Centers for Medicare and Medicaid Services. Discussed potential benefit and coverage improvements under Medicare and Medicare Savings Programs. Discussed Section 1115 Medicaid expansion demonstration waivers (HHS, CMS). H.R. 2759, Mental Health Access Improvement Act - Discussed support of bill. Discussed MACRA implementation. Discussed Medicare enrollment and coverage issues such as: provider access, direct billing and penalties. Discussed DOJ investigation regarding Olmstead and ADA violations by South Dakota (DOJ, ACL) and related public events. Discussed Olmstead enforcement and older adults at roundtable discussion. S. 3096, Removing Barriers to Person-Centered Care Act of 2016 - Discussed and provided feedback. Discussed possible hearing witnesses. Responded to inquiry regarding MACRA rules and value modifier. H.R. 3298, Post Acute Care Value Based Purchasing Act - Discussed and provided feedback. Discussed arbitration provision in LTC facility requirements proposed rule (OMB, CMS, HHS). Responded to inquiry on Virtual Caregiving Fair. PL 111-148 - Discussed ACA Medicaid HCBS spousal impoverishment provisions. Responded to inquiry on state nursing home legislation. Discussed Medicaid assisted living, HCBS setting rule and follow-up (GAO). Discussed Medicare home health (CMS). Urged support for family caregivers in Medicare and Medicaid and testing modeling. Signed letter to CMS regarding arbitration in LTC facility requirements rule. Discussed family caregiver assessment guidance (CMS). Attended PPI home health roundtable with staff from HHS. Responded to a question about a scorecard and letters to CMS. Responded to an inquiry regarding an arbitration regulatory provision. Responded to an inquiry regarding personal needs allowances. Discussed Medicaid functional assessment tools, family caregiver assessment, and follow-up(GAO). Responded to inquiries regarding Medicaid managed long-term services and supports, best practices, and state ombuds programs. S. 3130, Independence at Home Act - Discussed and sent AARP endorsement letter for bill

S. 3040, H.R. 5926, H.R. 5325, H.R. 2028, Labor, Health and Human Services Appropriations bill, FY2017 - Lobbied in support of increased funding for CMS' state survey and certification program. Discussed Medicaid per capita caps and block grants. Discussed DOJ investigation regarding findings of Olmstead and ADA violations by South Dakota. Discussed Olmstead and older adults roundtable and next steps (Administration for Community Living). Discussed arbitration provision in long-term care facility requirements final rule and related issues (no bill, Senate) and discussed final rule in general (CMS webinar). Provided information regarding Medicaid managed long-term services and supports and discussed family caregiver assessment in Medicaid home and community-based services. Discussed impending nursing home closure and resident relocation in the Virgin Islands and related issues. Discussed extension of the Money Follows the Person Rebalancing Demonstration Program. Discussed long-term services and supports financing, Social Security Caregiver Credit Act of 2015 (H.R. 3377), and family caregiving. S. 3504, Creating High-Quality Results and Outcomes Necessary to Improve Chronic (CHRONIC) Care Act - Discussed and provided feedback on draft bill. PL 113-185, Participated in CMS call on the Improving Medicare Post-Acute Care Transformation (IMPACT) Act of 2014. Discussed caregiver-focused health risk assessment in Medicare physician fee schedule final rule. Discussed AARP statement on Medicare physician fee schedule. S. 843, H.R. 1571, Improving Access to Medicare Coverage Act of 2015 - Discussed bill. Discussed health care quality and measurement. Discussed changes to the Medicare benefit design, such as copays, premiums, and deductibles. Discussed MACRA implementation. P.L. 111-148, P.L. 111-152 - Discussed potential repeal of Affordable Care Act. S. 9 - Sent endorsement letter for the Over the Counter Hearing Aid Act of 2016.

H.R. 1270, S.709, Restoring Access to Medication Act - Meetings, calls and emails urging support. H.R. 3590 - Halt Tax Increases on the Middle Class and Seniors Act - Meetings, calls and emails urging support. Lobbied the Centers for Medicare and Medicaid Services on the 2017 Medicare Advantage Advance Notice and Medicare Part D Call Letter. Discussed the Fair Medical Billing Act. (no bill #) Discussed Medicare Advantage, Medicare Supplemental and employer health insurance. Discussed Global Council on Brain Health, brain health generally and Alzheimer's. (no bill #) S. 192, Older Americans Act - Discussed reauthorization and urged congressional offices to sign letter of support. Discussed Affordable Care Act Medicaid expansion issues, including AARP comments on state 1115 waiver proposals to expand Medicaid. Discussed Medicare-Medicaid integration efforts and financial alignment demonstrations, other CMS demonstration initiatives. (no bill #) Discussed Older Americans Act home and community-based services program funding for FY2017. Discussed nutrition programs including the Supplemental Nutrition Assistance Program (SNAP)and related changes under the 2014 farm bill. H.R.1220, S.624, Removing Barriers to Colorectal Cancer Screening Act - Discussed bill. Labor, Health and Human Services Appropriations, FY2017 - Lobbied for funding support for various health and health care related programs serving seniors. (no bill #)

S. 709, H.R. 1270,Restoring Access to Medication Act - Meetings, calls and emails urging support. H.R. 3590 - Halt Tax Increases on the Middle Class and Seniors Act - Meetings, calls and emails urging support. Discussed the Fair Medical Billing Act. (no bill #) Discussed Medicare Advantage, Medicare Supplemental and employer health insurance. S. 192, Older Americans Act - Discussed reauthorization. Discussed Affordable Care Act Medicaid expansion issues, including AARP comments on state 1115 waiver proposals to expand Medicaid. Discussed Medicare-Medicaid integration efforts and financial alignment demonstrations, other CMS demonstration initiatives. Discussed Older Americans Act home and community-based services program funding for FY2017. S. 2956, H.R. 5054 - Discussed nutrition programs including the Supplemental Nutrition Assistance Program (SNAP)and related changes under the 2014 farm bill. S. 624, H.R.1220, Removing Barriers to Colorectal Cancer Screening Act - Discussed bill. S. 3040, Labor, Health and Human Services Appropriations, FY2017 - Lobbied for funding support for various health and health care related programs serving seniors. (no bill #) S.311, Seniors Tax Hike Prevention Act - Discussed medical expense deduction for the 65 plus population. Advocated on the issue of limited age rating for private health insurance. Advocated on the medical expense tax deduction. Shared comment letters on SNAP with Agriculture Committee staff.

S. 709, H.R. 1270, Restoring Access to Medication Act - Supported bill. H.R. 3590, Halt Tax Increases on the Middle Class and Seniors Act - Meetings, calls and emails urging support. Discussed the Fair Medical Billing Act. Discussed Medicare Advantage, Medicare Supplemental and employer health insurance. Discussed Affordable Care Act Medicaid expansion issues, including AARP comments on state 1115 waiver proposals to expand Medicaid. Discussed Medicare-Medicaid integration efforts and financial alignment demonstrations, other CMS demonstration initiatives. Discussed Older Americans Act home and community-based services program funding for FY2017. S. 2956, H.R. 5054 - Discussed nutrition programs including the Supplemental Nutrition Assistance Program (SNAP)and related changes under the 2014 farm bill. S. 3040, H.R. 5926, H.R. 5325, Labor, Health and Human Services Appropriations, FY2017 - Lobbied for funding support for various health and health care related programs serving seniors. S.3111, Seniors Tax Hike Prevention Act - Discussed medical expense deduction for the 65 plus population. Advocated on the issue of limited age rating for private health insurance. S. 3335, H.R. 6043, FAIR Drug Pricing Act - Supported bill.

Responded to inquiry regarding in-home supportive services programs. (no bill #) S. 1549, Care Planning Act - Discussed the bill and urged cosponsorship. Discussed structural changes to Medicaid. (no bill #) Discussed health care quality and measurement. (no bill #) Discussed changes to the Medicare benefit design, such as copays, premiums and deductibles. (no bill #) Discussed Personalize Your Care Act and provided feedback. (no bill #) Discussed Money Follows the Person Rebalancing Demonstration. (no bill #) Made inquiry regarding DC Medicaid HCBS waiver. (no bill #) S. 1085, Military and Veteran Caregiver Services Improvement Act - Discussed bill. H.R. 4878, Better Care Lower Cost Act - Discussed bill. Discussed spousal impoverishment in Medicaid. (no bill #) H.R. 4059, S.2297, Medicare Choices Empowerment and Protection Act - Provided feedback on bill. H.R. 3298, Medicare Post-Acute Care Value-Based Purchasing Act - Discussed feedback and next steps. (no bill #) Inquired regarding final rule on discharge planning. (no bill #) H.R.1571, Improving Access to Medicare Coverage Act - Discussed bill. Discussed retroactive eligibility for Medicaid HCBS (no bill #) Discussed observations status issues. (no bill #) S.578, Home Health Planning Improvement Act - Discussed bill and urged cosponsorship. Discussed the Medicare Part D prescription drug benefit program and changes needed to lower prescription drug costs and related agency proposed rule changes. (no bill #) H.R.2005, S.1083 - Discussed legislation to require drug manufacturers to provide rebates for drugs provided to Medicare Part D low-income subsidy beneficiaries, including those who are dually eligible for Medicare and Medicaid. H.R. 2624, S.1488, Part D Beneficiary Appeals Fairness Act- Discussed bill that would allow seniors to appeal the placement of their medications on a Medicare Part D specialty tier. Discussed Medicare Part D fraud and abuse legislation including lock-in provisions for high risk enrollees. (no bill #) Discussed legislation to require the addition of unique device identifier (UDI) of medical devices in health insurance claim forms. Discussed the Medicare Part B prescription drug demonstration proposal from the Centers for Medicare and Medicaid Services. H.R.1220, S.624, Removing Barriers to Colorectal Cancer Screening Act - Discussed bill. Discussed Medicare site of service payment policy. (no bill #) H.R. 4442,S.2484,CONNECT Act - Sent letter of endorsement. Discussed Medicare coverage and reimbursement of cataract surgery. Labor, Health and Human Services,FY2017 - Lobbied in support of increased funding for CMS' state survey and certification program. (no bill #)

Responded to inquiry regarding in-home supportive services programs. (no bill #) S. 1549, Care Planning Act - Discussed the bill and urged cosponsorship. Discussed structural changes to Medicaid. (no bill #) Discussed health care quality and measurement. (no bill #) Discussed changes to the Medicare benefit design, such as copays, premiums and deductibles. (no bill #) Discussed Personalize Your Care Act and provided feedback. (no bill #) Discussed Money Follows the Person Rebalancing Demonstration. (no bill #) Made inquiry regarding DC Medicaid HCBS waiver. (no bill #) S. 1085, Military and Veteran Caregiver Services Improvement Act - Discussed bill. H.R. 4878, Better Care Lower Cost Act - Discussed bill. Discussed spousal impoverishment in Medicaid. (no bill #) H.R. 4059, S.2297, Medicare Choices Empowerment and Protection Act - Provided feedback on bill. H.R. 3298, Medicare Post-Acute Care Value-Based Purchasing Act - Discussed feedback and next steps. (no bill #) Inquired regarding final rule on discharge planning. (no bill #) H.R.1571, Improving Access to Medicare Coverage Act - Discussed bill. Discussed retroactive eligibility for Medicaid HCBS (no bill #) Discussed observations status issues. (no bill #) S.578, Home Health Planning Improvement Act - Discussed bill and urged cosponsorship. Discussed the Medicare Part D prescription drug benefit program and changes needed to lower prescription drug costs and related agency proposed rule changes. (no bill #) H.R.2005, S.1083 - Discussed legislation to require drug manufacturers to provide rebates for drugs provided to Medicare Part D low-income subsidy beneficiaries, including those who are dually eligible for Medicare and Medicaid. H.R. 2624, S.1488, Part D Beneficiary Appeals Fairness Act- Discussed bill that would allow seniors to appeal the placement of their medications on a Medicare Part D specialty tier. Discussed Medicare Part D fraud and abuse legislation including lock-in provisions for high risk enrollees. (no bill #) Discussed legislation to require the addition of unique device identifier (UDI) of medical devices in health insurance claim forms. Discussed the Medicare Part B prescription drug demonstration proposal from the Centers for Medicare and Medicaid Services. H.R.1220, S.624, Removing Barriers to Colorectal Cancer Screening Act - Discussed bill. Discussed Medicare site of service payment policy. (no bill #) H.R. 4442,S.2484,CONNECT Act - Sent letter of endorsement. Discussed Medicare coverage and reimbursement of cataract surgery. Labor, Health and Human Services,FY2017 - Lobbied in support of increased funding for CMS' state survey and certification program. (no bill #)

Responded to inquiry regarding in-home supportive services programs. (no bill #) S. 1549, Care Planning Act - Discussed the bill and urged cosponsorship. Discussed structural changes to Medicaid. (no bill #) Discussed health care quality and measurement. (no bill #) Discussed changes to the Medicare benefit design, such as copays, premiums and deductibles. (no bill #) Discussed Personalize Your Care Act and provided feedback. (no bill #) Discussed Money Follows the Person Rebalancing Demonstration. (no bill #) Made inquiry regarding DC Medicaid HCBS waiver. (no bill #) S. 1085, Military and Veteran Caregiver Services Improvement Act - Discussed bill. H.R. 4878, Better Care Lower Cost Act - Discussed bill. Discussed spousal impoverishment in Medicaid. (no bill #) H.R. 4059, S.2297, Medicare Choices Empowerment and Protection Act - Provided feedback on bill. H.R. 3298, Medicare Post-Acute Care Value-Based Purchasing Act - Discussed feedback and next steps. (no bill #) Inquired regarding final rule on discharge planning. (no bill #) H.R.1571, Improving Access to Medicare Coverage Act - Discussed bill. Discussed retroactive eligibility for Medicaid HCBS (no bill #) Discussed observations status issues. (no bill #) S.578, Home Health Planning Improvement Act - Discussed bill and urged cosponsorship. Discussed the Medicare Part D prescription drug benefit program and changes needed to lower prescription drug costs and related agency proposed rule changes. (no bill #) H.R.2005, S.1083 - Discussed legislation to require drug manufacturers to provide rebates for drugs provided to Medicare Part D low-income subsidy beneficiaries, including those who are dually eligible for Medicare and Medicaid. H.R. 2624, S.1488, Part D Beneficiary Appeals Fairness Act- Discussed bill that would allow seniors to appeal the placement of their medications on a Medicare Part D specialty tier. Discussed Medicare Part D fraud and abuse legislation including lock-in provisions for high risk enrollees. (no bill #) Discussed legislation to require the addition of unique device identifier (UDI) of medical devices in health insurance claim forms. Discussed the Medicare Part B prescription drug demonstration proposal from the Centers for Medicare and Medicaid Services. H.R.1220, S.624, Removing Barriers to Colorectal Cancer Screening Act - Discussed bill. Discussed Medicare site of service payment policy. (no bill #) H.R. 4442,S.2484,CONNECT Act - Sent letter of endorsement. Discussed Medicare coverage and reimbursement of cataract surgery. Labor, Health and Human Services,FY2017 - Lobbied in support of increased funding for CMS' state survey and certification program. (no bill #)

Responded to inquiry regarding in-home supportive services programs. S. 1549, Care Planning Act - Discussed the bill and urged cosponsorship. Discussed structural changes to Medicaid. Discussed health care quality and measurement. Discussed changes to the Medicare benefit design, such as copays, premiums and deductibles. H.R.1571, Improving Access to Medicare Coverage Act - Discussed bill. S.578, Home Health Planning Improvement Act - Discussed bill and urged cosponsorship. Discussed the Medicare Part D prescription drug benefit program and changes needed to lower prescription drug costs and related agency proposed rule changes. S. 1083, H.R.2005 - Discussed legislation to require drug manufacturers to provide rebates for drugs provided to Medicare Part D low-income subsidy beneficiaries, including those who are dually eligible for Medicare and Medicaid. S. 1488, H.R. 2624, Part D Beneficiary Appeals Fairness Act - Discussed bill that would allow seniors to appeal the placement of their medications on a Medicare Part D specialty tier. Discussed Medicare Part D fraud and abuse legislation including lock-in provisions for high risk enrollees. Discussed legislation to require the addition of unique device identifier (UDI) of medical devices in health insurance claim forms. Discussed the Medicare Part B prescription drug demonstration proposal from the Centers for Medicare and Medicaid Services. S. 624, H.R.1220,Removing Barriers to Colorectal Cancer Screening Act - Discussed bill. S. 3040, Labor, Health and Human Services,FY2017 - Lobbied in support of increased funding for CMS' state survey and certification program. S. 1549 - Discussed support of Care Planning Act. Discussed the Medicare Part B prescription drug benefit program and changes needed to lower prescription drug costs and related agency proposed rule changes. H.R. 5122 - Discussed the Medicare Part B prescription drug demonstration proposal. Discussed potential benefit and coverage improvements under Medicare and Medicaid Savings Programs. H.R. 2759, Mental Health Access Improvement Act - Discussed support of bill. Discussed MACRA implementation. Discussed Medicare enrollment and coverage issues such as: provider access, direct billing and penalties. S. 1719, H.R. 3099, RAISE Act - Discussed CMS' efforts regarding family caregiving. Provided feedback on advanced directive registry bill. (no bill #) Discussed independence at home legislation. S. 2961, Compassionate Care Act - Discussed our position and provided feedback. Discussed DOJ investigation regarding Olmstead and ADA violations by South Dakota and provided feedback (DOJ). Responded to inquiry regarding roundtable (ACL). S. 3096, Removing Barriers to Person-Centered Care Act of 2016 - Discussed and provided feedback. Discussed possible hearing witnesses. Discussed Medicaid HCBS spousal impoverishment bill. (no bill #) Responded to inquiry regarding MACRA rules and value modifier. Discussed Medicare's 180-day coverage of skilled nursing facility care. S. 2836, H.R. 5036, Protecting Families with Disabilities Act - Signed letter in support of bill.

S. 709, H.R. 1270, Restoring Access to Medication Act - Supported bill. H.R. 3590, Halt Tax Increases on the Middle Class and Seniors Act - Meetings, calls and emails urging support. Discussed the Fair Medical Billing Act. Discussed Medicare Advantage, Medicare Supplemental and employer health insurance. Discussed Affordable Care Act Medicaid expansion issues, including AARP comments on state 1115 waiver proposals to expand Medicaid. Discussed Medicare-Medicaid integration efforts and financial alignment demonstrations, other CMS demonstration initiatives. Discussed Older Americans Act home and community-based services program funding for FY2017. S. 2956, H.R. 5054 - Discussed nutrition programs including the Supplemental Nutrition Assistance Program (SNAP)and related changes under the 2014 farm bill. S. 3040, H.R. 5926, H.R. 5325, Labor, Health and Human Services Appropriations, FY2017 - Lobbied for funding support for various health and health care related programs serving seniors. S.3111, Seniors Tax Hike Prevention Act - Discussed medical expense deduction for the 65 plus population. Advocated on the issue of limited age rating for private health insurance. S. 3335, H.R. 6043, FAIR Drug Pricing Act - Supported bill.

H.R.6 - Discussed the House Energy and Commerce Committee 21st Century Cures Initiative and Senate HELP Committee efforts focused on drug and medical device innovation issues. S. 31, H.R. 3061 - Discussed the importance of potential savings to both consumers and the federal government of granting Secretarial negotiating authority to the HHS Secretary under Medicare Part D. S. 2019 - Discussed legislation to address pay-for-delay agreements used by drug manufacturers to block lower cost drugs from entering the market. S. 3094, H.R. 5573 - Discussed legislation to reduce the market exclusivity period for biologic drugs. Discussed biologic drug issues including implementation of the new approval pathway for biosimilar drugs. S. 3335, H.R. 6043 - Discussed the need for price transparency on prescription drug prices and comparativeness effectiveness research. Discussed legislation to address the opioid abuse epidemic including fraud and abuse provisions. Discussed opioid issues generally. S. 3056 - Discussed legislation to address abuse of Risk-Evaluation and Mitigation Strategies (REMS) by brand name drug companies to block lower-cost generic drugs from entering the market. S. 3455 - Discussed legislation to allow temporary importation authority in cases of drug shortages and non-competitive markets. S. 2956, H.R. 5054, H.R. 5325, H.R. 2028, Agriculture Appropriations, FY2017 - Lobbied in support of FDA funding. H.R. 6043, FAIR Drug Pricing Act - Supported bill to require manufactures of certain drugs and biological products to report to HHS price increases that result in a 10% or more increase in the price of a drug over a 12 month period.

H.R.6 - Discussed the House Energy and Commerce Committee 21st Century Cures Initiative and Senate HELP Committee efforts focused on drug and medical device innovation issues. S. 31, H.R. 3061 - Discussed the importance of potential savings to both consumers and the federal government of granting Secretarial negotiating authority to the HHS Secretary under Medicare Part D. Discussed legislation to address pay-for-delay agreements used by drug manufacturers to block lower cost drugs from entering the market. S. 3094, H.R. 5573 - Discussed the exclusivity period for biologic drugs. Discussed biologic drug issues including implementation of the new approval pathway for biosimilar drugs. Discussed the need for price transparency on prescription drug prices and comparativeness effectiveness research. Discussed legislation to address the opioid abuse epidemic including fraud and abuse provisions. Discussed opioid issues generally. S. 3056 - Discussed legislation to address abuse of Risk-Evaluation and Mitigation Strategies (REMS) by brand name drug companies to block lower-cost generic drugs from entering the market. S. 1137, H.R. 9, Innovation Act, PATENT Act - Discussed patent reform legislation and related provisions on the Patent and Trademark Office inter partes review (IPR) process and proposed exemptions for brand name drug patents. S. 2956, H.R. 5054, Agriculture Appropriations, FY2017 - Lobbied in support of FDA funding. Responded to inquiry regarding Medicare Part B demonstration.

H.R.6 - Discussed the House Energy and Commerce Committee 21st Century Cures Initiative and Senate HELP Committee efforts focused on drug and medical device innovation issues. S. 31, H.R. 3061 - Discussed the importance of potential savings to both consumers and the federal government of granting Secretarial negotiating authority to the HHS Secretary under Medicare Part D. S. 2019 - Discussed legislation to address pay-for-delay agreements used by drug manufacturers to block lower cost drugs from entering the market. S. 3094, H.R. 5573 - Discussed legislation to reduce the market exclusivity period for biologic drugs. Discussed biologic drug issues including implementation of the new approval pathway for biosimilar drugs. S. 3335, H.R. 6043 - Discussed the need for price transparency on prescription drug prices and comparativeness effectiveness research. Discussed legislation to address the opioid abuse epidemic including fraud and abuse provisions. Discussed opioid issues generally. S. 3056 - Discussed legislation to address abuse of Risk-Evaluation and Mitigation Strategies (REMS) by brand name drug companies to block lower-cost generic drugs from entering the market. S. 3455 - Discussed legislation to allow temporary importation authority in cases of drug shortages and non-competitive markets. S. 2956, H.R. 5054, H.R. 5325, Agriculture Appropriations, FY2017 - Lobbied in support of FDA funding. H.R. 6043, FAIR Drug Pricing Act - Supported bill to require manufactures of certain drugs and biological products to report to HHS price increases that result in a 10% or more increase in the price of a drug over a 12 month period.

S. 709, H.R. 1270,Restoring Access to Medication Act - Meetings, calls and emails urging support. H.R. 3590 - Halt Tax Increases on the Middle Class and Seniors Act - Meetings, calls and emails urging support. Discussed the Fair Medical Billing Act. (no bill #) Discussed Medicare Advantage, Medicare Supplemental and employer health insurance. S. 192, Older Americans Act - Discussed reauthorization. Discussed Affordable Care Act Medicaid expansion issues, including AARP comments on state 1115 waiver proposals to expand Medicaid. Discussed Medicare-Medicaid integration efforts and financial alignment demonstrations, other CMS demonstration initiatives. Discussed Older Americans Act home and community-based services program funding for FY2017. S. 2956, H.R. 5054 - Discussed nutrition programs including the Supplemental Nutrition Assistance Program (SNAP)and related changes under the 2014 farm bill. S. 624, H.R.1220, Removing Barriers to Colorectal Cancer Screening Act - Discussed bill. S. 3040, Labor, Health and Human Services Appropriations, FY2017 - Lobbied for funding support for various health and health care related programs serving seniors. (no bill #) S.311, Seniors Tax Hike Prevention Act - Discussed medical expense deduction for the 65 plus population. Advocated on the issue of limited age rating for private health insurance. Advocated on the medical expense tax deduction. Shared comment letters on SNAP with Agriculture Committee staff.

Discussed structural changes to Medicaid. Discussed health care quality and measurement. Discussed changes to the Medicare benefit design, such as copays, premiums and deductibles. S. 1083, H.R.2005 - Discussed legislation to require drug manufacturers to provide rebates for drugs provided to Medicare Part D low-income subsidy beneficiaries, including those who are dually eligible for Medicare and Medicaid. S. 1488, H.R. 2624, Part D Beneficiary Appeals Fairness Act - Discussed bill that would allow seniors to appeal the placement of their medications on a Medicare Part D specialty tier. Discussed Medicare Part D fraud and abuse legislation including lock-in provisions for high risk enrollees. Discussed legislation to require the addition of unique device identifier (UDI) of medical devices in health insurance claim forms. S. 624, H.R.1220, Removing Barriers to Colorectal Cancer Screening Act - Discussed bill. S. 3040, H.R. 5926, H.R. 5325, Labor, Health and Human Services Appropriations bill, FY2017 - Lobbied in support of increased funding for CMS' state survey and certification program. Discussed the Medicare Part D prescription drug benefit program and changes needed to lower prescription drug costs and related agency proposed rule changes. H.R. 5122 - Discussed the Medicare Part B prescription drug demonstration proposal from the Centers for Medicare and Medicaid Services. Discussed potential benefit and coverage improvements under Medicare and Medicare Savings Programs. Discussed Section 1115 Medicaid expansion demonstration waivers (HHS, CMS). H.R. 2759, Mental Health Access Improvement Act - Discussed support of bill. Discussed MACRA implementation. Discussed Medicare enrollment and coverage issues such as: provider access, direct billing and penalties. Discussed DOJ investigation regarding Olmstead and ADA violations by South Dakota (DOJ, ACL) and related public events. Discussed Olmstead enforcement and older adults at roundtable discussion. S. 3096, Removing Barriers to Person-Centered Care Act of 2016 - Discussed and provided feedback. Discussed possible hearing witnesses. Responded to inquiry regarding MACRA rules and value modifier. H.R. 3298, Post Acute Care Value Based Purchasing Act - Discussed and provided feedback. Discussed arbitration provision in LTC facility requirements proposed rule (OMB, CMS, HHS). Responded to inquiry on Virtual Caregiving Fair. PL 111-148 - Discussed ACA Medicaid HCBS spousal impoverishment provisions. Responded to inquiry on state nursing home legislation. Discussed Medicaid assisted living, HCBS setting rule and follow-up (GAO). Discussed Medicare home health (CMS). Urged support for family caregivers in Medicare and Medicaid and testing modeling. Signed letter to CMS regarding arbitration in LTC facility requirements rule. Discussed family caregiver assessment guidance (CMS). Attended PPI home health roundtable with staff from HHS. Responded to a question about a scorecard and letters to CMS. Responded to an inquiry regarding an arbitration regulatory provision. Responded to an inquiry regarding personal needs allowances. Discussed Medicaid functional assessment tools, family caregiver assessment, and follow-up(GAO). Responded to inquiries regarding Medicaid managed long-term services and supports, best practices, and state ombuds programs. S. 3130, Independence at Home Act - Discussed and sent AARP endorsement letter for bill

Responded to inquiry regarding in-home supportive services programs. S. 1549, Care Planning Act - Discussed the bill and urged cosponsorship. Discussed structural changes to Medicaid. Discussed health care quality and measurement. Discussed changes to the Medicare benefit design, such as copays, premiums and deductibles. H.R.1571, Improving Access to Medicare Coverage Act - Discussed bill. S.578, Home Health Planning Improvement Act - Discussed bill and urged cosponsorship. Discussed the Medicare Part D prescription drug benefit program and changes needed to lower prescription drug costs and related agency proposed rule changes. S. 1083, H.R.2005 - Discussed legislation to require drug manufacturers to provide rebates for drugs provided to Medicare Part D low-income subsidy beneficiaries, including those who are dually eligible for Medicare and Medicaid. S. 1488, H.R. 2624, Part D Beneficiary Appeals Fairness Act - Discussed bill that would allow seniors to appeal the placement of their medications on a Medicare Part D specialty tier. Discussed Medicare Part D fraud and abuse legislation including lock-in provisions for high risk enrollees. Discussed legislation to require the addition of unique device identifier (UDI) of medical devices in health insurance claim forms. Discussed the Medicare Part B prescription drug demonstration proposal from the Centers for Medicare and Medicaid Services. S. 624, H.R.1220,Removing Barriers to Colorectal Cancer Screening Act - Discussed bill. S. 3040, Labor, Health and Human Services,FY2017 - Lobbied in support of increased funding for CMS' state survey and certification program. S. 1549 - Discussed support of Care Planning Act. Discussed the Medicare Part B prescription drug benefit program and changes needed to lower prescription drug costs and related agency proposed rule changes. H.R. 5122 - Discussed the Medicare Part B prescription drug demonstration proposal. Discussed potential benefit and coverage improvements under Medicare and Medicaid Savings Programs. H.R. 2759, Mental Health Access Improvement Act - Discussed support of bill. Discussed MACRA implementation. Discussed Medicare enrollment and coverage issues such as: provider access, direct billing and penalties. S. 1719, H.R. 3099, RAISE Act - Discussed CMS' efforts regarding family caregiving. Provided feedback on advanced directive registry bill. (no bill #) Discussed independence at home legislation. S. 2961, Compassionate Care Act - Discussed our position and provided feedback. Discussed DOJ investigation regarding Olmstead and ADA violations by South Dakota and provided feedback (DOJ). Responded to inquiry regarding roundtable (ACL). S. 3096, Removing Barriers to Person-Centered Care Act of 2016 - Discussed and provided feedback. Discussed possible hearing witnesses. Discussed Medicaid HCBS spousal impoverishment bill. (no bill #) Responded to inquiry regarding MACRA rules and value modifier. Discussed Medicare's 180-day coverage of skilled nursing facility care. S. 2836, H.R. 5036, Protecting Families with Disabilities Act - Signed letter in support of bill.

Discussed structural changes to Medicaid. Discussed health care quality and measurement. Discussed changes to the Medicare benefit design, such as copays, premiums and deductibles. S. 1083, H.R.2005 - Discussed legislation to require drug manufacturers to provide rebates for drugs provided to Medicare Part D low-income subsidy beneficiaries, including those who are dually eligible for Medicare and Medicaid. S. 1488, H.R. 2624, Part D Beneficiary Appeals Fairness Act - Discussed bill that would allow seniors to appeal the placement of their medications on a Medicare Part D specialty tier. Discussed Medicare Part D fraud and abuse legislation including lock-in provisions for high risk enrollees. Discussed legislation to require the addition of unique device identifier (UDI) of medical devices in health insurance claim forms. S. 624, H.R.1220, Removing Barriers to Colorectal Cancer Screening Act - Discussed bill. S. 3040, H.R. 5926, H.R. 5325, Labor, Health and Human Services Appropriations bill, FY2017 - Lobbied in support of increased funding for CMS' state survey and certification program. Discussed the Medicare Part D prescription drug benefit program and changes needed to lower prescription drug costs and related agency proposed rule changes. H.R. 5122 - Discussed the Medicare Part B prescription drug demonstration proposal from the Centers for Medicare and Medicaid Services. Discussed potential benefit and coverage improvements under Medicare and Medicare Savings Programs. Discussed Section 1115 Medicaid expansion demonstration waivers (HHS, CMS). H.R. 2759, Mental Health Access Improvement Act - Discussed support of bill. Discussed MACRA implementation. Discussed Medicare enrollment and coverage issues such as: provider access, direct billing and penalties. Discussed DOJ investigation regarding Olmstead and ADA violations by South Dakota (DOJ, ACL) and related public events. Discussed Olmstead enforcement and older adults at roundtable discussion. S. 3096, Removing Barriers to Person-Centered Care Act of 2016 - Discussed and provided feedback. Discussed possible hearing witnesses. Responded to inquiry regarding MACRA rules and value modifier. H.R. 3298, Post Acute Care Value Based Purchasing Act - Discussed and provided feedback. Discussed arbitration provision in LTC facility requirements proposed rule (OMB, CMS, HHS). Responded to inquiry on Virtual Caregiving Fair. PL 111-148 - Discussed ACA Medicaid HCBS spousal impoverishment provisions. Responded to inquiry on state nursing home legislation. Discussed Medicaid assisted living, HCBS setting rule and follow-up (GAO). Discussed Medicare home health (CMS). Urged support for family caregivers in Medicare and Medicaid and testing modeling. Signed letter to CMS regarding arbitration in LTC facility requirements rule. Discussed family caregiver assessment guidance (CMS). Attended PPI home health roundtable with staff from HHS. Responded to a question about a scorecard and letters to CMS. Responded to an inquiry regarding an arbitration regulatory provision. Responded to an inquiry regarding personal needs allowances. Discussed Medicaid functional assessment tools, family caregiver assessment, and follow-up(GAO). Responded to inquiries regarding Medicaid managed long-term services and supports, best practices, and state ombuds programs. S. 3130, Independence at Home Act - Discussed and sent AARP endorsement letter for bill

S. 3040, H.R. 5926, H.R. 5325, H.R. 2028, Labor, Health and Human Services Appropriations bill, FY2017 - Lobbied in support of increased funding for CMS' state survey and certification program. Discussed Medicaid per capita caps and block grants. Discussed DOJ investigation regarding findings of Olmstead and ADA violations by South Dakota. Discussed Olmstead and older adults roundtable and next steps (Administration for Community Living). Discussed arbitration provision in long-term care facility requirements final rule and related issues (no bill, Senate) and discussed final rule in general (CMS webinar). Provided information regarding Medicaid managed long-term services and supports and discussed family caregiver assessment in Medicaid home and community-based services. Discussed impending nursing home closure and resident relocation in the Virgin Islands and related issues. Discussed extension of the Money Follows the Person Rebalancing Demonstration Program. Discussed long-term services and supports financing, Social Security Caregiver Credit Act of 2015 (H.R. 3377), and family caregiving. S. 3504, Creating High-Quality Results and Outcomes Necessary to Improve Chronic (CHRONIC) Care Act - Discussed and provided feedback on draft bill. PL 113-185, Participated in CMS call on the Improving Medicare Post-Acute Care Transformation (IMPACT) Act of 2014. Discussed caregiver-focused health risk assessment in Medicare physician fee schedule final rule. Discussed AARP statement on Medicare physician fee schedule. S. 843, H.R. 1571, Improving Access to Medicare Coverage Act of 2015 - Discussed bill. Discussed health care quality and measurement. Discussed changes to the Medicare benefit design, such as copays, premiums, and deductibles. Discussed MACRA implementation. P.L. 111-148, P.L. 111-152 - Discussed potential repeal of Affordable Care Act. S. 9 - Sent endorsement letter for the Over the Counter Hearing Aid Act of 2016.

H.R.6 - Discussed the House Energy and Commerce Committee 21st Century Cures Initiative and Senate HELP Committee efforts focused on drug and medical device innovation issues. S. 31, H.R. 3061 - Discussed the importance of potential savings to both consumers and the federal government of granting Secretarial negotiating authority to the HHS Secretary under Medicare Part D. S. 2019 - Discussed legislation to address pay-for-delay agreements used by drug manufacturers to block lower cost drugs from entering the market. S. 3094, H.R. 5573 - Discussed legislation to reduce the market exclusivity period for biologic drugs. Discussed biologic drug issues including implementation of the new approval pathway for biosimilar drugs. S. 3335, H.R. 6043 - Discussed the need for price transparency on prescription drug prices and comparativeness effectiveness research. Discussed legislation to address the opioid abuse epidemic including fraud and abuse provisions. Discussed opioid issues generally. S. 3056 - Discussed legislation to address abuse of Risk-Evaluation and Mitigation Strategies (REMS) by brand name drug companies to block lower-cost generic drugs from entering the market. S. 3455 - Discussed legislation to allow temporary importation authority in cases of drug shortages and non-competitive markets. S. 2956, H.R. 5054, H.R. 5325, Agriculture Appropriations, FY2017 - Lobbied in support of FDA funding. H.R. 6043, FAIR Drug Pricing Act - Supported bill to require manufactures of certain drugs and biological products to report to HHS price increases that result in a 10% or more increase in the price of a drug over a 12 month period.

S. 3040, H.R. 5926, H.R. 5325,H.R. 2028, Labor, Health and Human Services Appropriations, FY2017 - Lobbied for funding support for various health and health care related programs serving seniors. S.3111, Seniors Tax Hike Prevention Act - Discussed medical expense deduction for the 65 plus population. Advocated on the issue of limited age rating for private health insurance. S. 3335, H.R. 6043, FAIR Drug Pricing Act - Supported bill. Discussed the Confidence in Long-Term Care Insurance Act (S. 159)/Long-Term Care Insurance Reform Act (H.R. 63) (bill numbers are in the 112th Congress). Discussed ACA repeal, Medicare, and Medicaid.

H.R.6 - Discussed the House Energy and Commerce Committee 21st Century Cures Initiative and Senate HELP Committee efforts focused on drug and medical device innovation issues. S. 31, H.R. 3061 - Discussed the importance of potential savings to both consumers and the federal government of granting Secretarial negotiating authority to the HHS Secretary under Medicare Part D. S. 2019 - Discussed legislation to address pay-for-delay agreements used by drug manufacturers to block lower cost drugs from entering the market. S. 3094, H.R. 5573 - Discussed legislation to reduce the market exclusivity period for biologic drugs. Discussed biologic drug issues including implementation of the new approval pathway for biosimilar drugs. S. 3335, H.R. 6043 - Discussed the need for price transparency on prescription drug prices and comparativeness effectiveness research. Discussed legislation to address the opioid abuse epidemic including fraud and abuse provisions. Discussed opioid issues generally. S. 3056 - Discussed legislation to address abuse of Risk-Evaluation and Mitigation Strategies (REMS) by brand name drug companies to block lower-cost generic drugs from entering the market. S. 3455 - Discussed legislation to allow temporary importation authority in cases of drug shortages and non-competitive markets. S. 2956, H.R. 5054, H.R. 5325, H.R. 2028, Agriculture Appropriations, FY2017 - Lobbied in support of FDA funding. H.R. 6043, FAIR Drug Pricing Act - Supported bill to require manufactures of certain drugs and biological products to report to HHS price increases that result in a 10% or more increase in the price of a drug over a 12 month period.

S. 709, H.R. 1270, Restoring Access to Medication Act - Supported bill. H.R. 3590, Halt Tax Increases on the Middle Class and Seniors Act - Meetings, calls and emails urging support. Discussed the Fair Medical Billing Act. Discussed Medicare Advantage, Medicare Supplemental and employer health insurance. Discussed Affordable Care Act Medicaid expansion issues, including AARP comments on state 1115 waiver proposals to expand Medicaid. Discussed Medicare-Medicaid integration efforts and financial alignment demonstrations, other CMS demonstration initiatives. Discussed Older Americans Act home and community-based services program funding for FY2017. S. 2956, H.R. 5054 - Discussed nutrition programs including the Supplemental Nutrition Assistance Program (SNAP)and related changes under the 2014 farm bill. S. 3040, H.R. 5926, H.R. 5325, Labor, Health and Human Services Appropriations, FY2017 - Lobbied for funding support for various health and health care related programs serving seniors. S.3111, Seniors Tax Hike Prevention Act - Discussed medical expense deduction for the 65 plus population. Advocated on the issue of limited age rating for private health insurance. S. 3335, H.R. 6043, FAIR Drug Pricing Act - Supported bill.

H.R.6 - Discussed the House Energy and Commerce Committee 21st Century Cures Initiative and Senate HELP Committee efforts focused on drug and medical device innovation issues. S. 31, H.R. 3061 - Discussed the importance of potential savings to both consumers and the federal government of granting Secretarial negotiating authority to the HHS Secretary under Medicare Part D. S. 2019 - Discussed legislation to address pay-for-delay agreements used by drug manufacturers to block lower cost drugs from entering the market. S. 3094, H.R. 5573 - Discussed legislation to reduce the market exclusivity period for biologic drugs. Discussed biologic drug issues including implementation of the new approval pathway for biosimilar drugs. S. 3335, H.R. 6043 - Discussed the need for price transparency on prescription drug prices and comparativeness effectiveness research. Discussed legislation to address the opioid abuse epidemic including fraud and abuse provisions. Discussed opioid issues generally. S. 3056 - Discussed legislation to address abuse of Risk-Evaluation and Mitigation Strategies (REMS) by brand name drug companies to block lower-cost generic drugs from entering the market. S. 3455 - Discussed legislation to allow temporary importation authority in cases of drug shortages and non-competitive markets. S. 2956, H.R. 5054, H.R. 5325, Agriculture Appropriations, FY2017 - Lobbied in support of FDA funding. H.R. 6043, FAIR Drug Pricing Act - Supported bill to require manufactures of certain drugs and biological products to report to HHS price increases that result in a 10% or more increase in the price of a drug over a 12 month period.

H.R.6 - Discussed the House Energy and Commerce Committee 21st Century Cures Initiative and Senate HELP Committee efforts focused on drug and medical device innovation issues. S. 31, H.R. 3061 - Discussed the importance of potential savings to both consumers and the federal government of granting Secretarial negotiating authority to the HHS Secretary under Medicare Part D. Discussed legislation to address pay-for-delay agreements used by drug manufacturers to block lower cost drugs from entering the market. S. 3094, H.R. 5573 - Discussed the exclusivity period for biologic drugs. Discussed biologic drug issues including implementation of the new approval pathway for biosimilar drugs. Discussed the need for price transparency on prescription drug prices and comparativeness effectiveness research. Discussed legislation to address the opioid abuse epidemic including fraud and abuse provisions. Discussed opioid issues generally. S. 3056 - Discussed legislation to address abuse of Risk-Evaluation and Mitigation Strategies (REMS) by brand name drug companies to block lower-cost generic drugs from entering the market. S. 1137, H.R. 9, Innovation Act, PATENT Act - Discussed patent reform legislation and related provisions on the Patent and Trademark Office inter partes review (IPR) process and proposed exemptions for brand name drug patents. S. 2956, H.R. 5054, Agriculture Appropriations, FY2017 - Lobbied in support of FDA funding. Responded to inquiry regarding Medicare Part B demonstration.

H.R.6 - Discussed the House Energy and Commerce Committee 21st Century Cures Initiative and Senate HELP Committee efforts focused on drug and medical device innovation issues. S. 31, H.R. 3061 - Discussed the importance of potential savings to both consumers and the federal government of granting Secretarial negotiating authority to the HHS Secretary under Medicare Part D. S. 2019 - Discussed legislation to address pay-for-delay agreements used by drug manufacturers to block lower cost drugs from entering the market. S. 3094, H.R. 5573 - Discussed legislation to reduce the market exclusivity period for biologic drugs. Discussed biologic drug issues including implementation of the new approval pathway for biosimilar drugs. S. 3335, H.R. 6043 - Discussed the need for price transparency on prescription drug prices and comparativeness effectiveness research. Discussed legislation to address the opioid abuse epidemic including fraud and abuse provisions. Discussed opioid issues generally. S. 3056 - Discussed legislation to address abuse of Risk-Evaluation and Mitigation Strategies (REMS) by brand name drug companies to block lower-cost generic drugs from entering the market. S. 3455 - Discussed legislation to allow temporary importation authority in cases of drug shortages and non-competitive markets. S. 2956, H.R. 5054, H.R. 5325, H.R. 2028, Agriculture Appropriations, FY2017 - Lobbied in support of FDA funding. H.R. 6043, FAIR Drug Pricing Act - Supported bill to require manufactures of certain drugs and biological products to report to HHS price increases that result in a 10% or more increase in the price of a drug over a 12 month period.

S. 709, H.R. 1270, Restoring Access to Medication Act - Supported bill. H.R. 3590, Halt Tax Increases on the Middle Class and Seniors Act - Meetings, calls and emails urging support. Discussed the Fair Medical Billing Act. Discussed Medicare Advantage, Medicare Supplemental and employer health insurance. Discussed Affordable Care Act Medicaid expansion issues, including AARP comments on state 1115 waiver proposals to expand Medicaid. Discussed Medicare-Medicaid integration efforts and financial alignment demonstrations, other CMS demonstration initiatives. Discussed Older Americans Act home and community-based services program funding for FY2017. S. 2956, H.R. 5054 - Discussed nutrition programs including the Supplemental Nutrition Assistance Program (SNAP)and related changes under the 2014 farm bill. S. 3040, H.R. 5926, H.R. 5325, Labor, Health and Human Services Appropriations, FY2017 - Lobbied for funding support for various health and health care related programs serving seniors. S.3111, Seniors Tax Hike Prevention Act - Discussed medical expense deduction for the 65 plus population. Advocated on the issue of limited age rating for private health insurance. S. 3335, H.R. 6043, FAIR Drug Pricing Act - Supported bill.

S. 3040, H.R. 5926, H.R. 5325, H.R. 2028, Labor, Health and Human Services Appropriations bill, FY2017 - Lobbied in support of increased funding for CMS' state survey and certification program. Discussed Medicaid per capita caps and block grants. Discussed DOJ investigation regarding findings of Olmstead and ADA violations by South Dakota. Discussed Olmstead and older adults roundtable and next steps (Administration for Community Living). Discussed arbitration provision in long-term care facility requirements final rule and related issues (no bill, Senate) and discussed final rule in general (CMS webinar). Provided information regarding Medicaid managed long-term services and supports and discussed family caregiver assessment in Medicaid home and community-based services. Discussed impending nursing home closure and resident relocation in the Virgin Islands and related issues. Discussed extension of the Money Follows the Person Rebalancing Demonstration Program. Discussed long-term services and supports financing, Social Security Caregiver Credit Act of 2015 (H.R. 3377), and family caregiving. S. 3504, Creating High-Quality Results and Outcomes Necessary to Improve Chronic (CHRONIC) Care Act - Discussed and provided feedback on draft bill. PL 113-185, Participated in CMS call on the Improving Medicare Post-Acute Care Transformation (IMPACT) Act of 2014. Discussed caregiver-focused health risk assessment in Medicare physician fee schedule final rule. Discussed AARP statement on Medicare physician fee schedule. S. 843, H.R. 1571, Improving Access to Medicare Coverage Act of 2015 - Discussed bill. Discussed health care quality and measurement. Discussed changes to the Medicare benefit design, such as copays, premiums, and deductibles. Discussed MACRA implementation. P.L. 111-148, P.L. 111-152 - Discussed potential repeal of Affordable Care Act. S. 9 - Sent endorsement letter for the Over the Counter Hearing Aid Act of 2016.

Discussed structural changes to Medicaid. Discussed health care quality and measurement. Discussed changes to the Medicare benefit design, such as copays, premiums and deductibles. S. 1083, H.R.2005 - Discussed legislation to require drug manufacturers to provide rebates for drugs provided to Medicare Part D low-income subsidy beneficiaries, including those who are dually eligible for Medicare and Medicaid. S. 1488, H.R. 2624, Part D Beneficiary Appeals Fairness Act - Discussed bill that would allow seniors to appeal the placement of their medications on a Medicare Part D specialty tier. Discussed Medicare Part D fraud and abuse legislation including lock-in provisions for high risk enrollees. Discussed legislation to require the addition of unique device identifier (UDI) of medical devices in health insurance claim forms. S. 624, H.R.1220, Removing Barriers to Colorectal Cancer Screening Act - Discussed bill. S. 3040, H.R. 5926, H.R. 5325, Labor, Health and Human Services Appropriations bill, FY2017 - Lobbied in support of increased funding for CMS' state survey and certification program. Discussed the Medicare Part D prescription drug benefit program and changes needed to lower prescription drug costs and related agency proposed rule changes. H.R. 5122 - Discussed the Medicare Part B prescription drug demonstration proposal from the Centers for Medicare and Medicaid Services. Discussed potential benefit and coverage improvements under Medicare and Medicare Savings Programs. Discussed Section 1115 Medicaid expansion demonstration waivers (HHS, CMS). H.R. 2759, Mental Health Access Improvement Act - Discussed support of bill. Discussed MACRA implementation. Discussed Medicare enrollment and coverage issues such as: provider access, direct billing and penalties. Discussed DOJ investigation regarding Olmstead and ADA violations by South Dakota (DOJ, ACL) and related public events. Discussed Olmstead enforcement and older adults at roundtable discussion. S. 3096, Removing Barriers to Person-Centered Care Act of 2016 - Discussed and provided feedback. Discussed possible hearing witnesses. Responded to inquiry regarding MACRA rules and value modifier. H.R. 3298, Post Acute Care Value Based Purchasing Act - Discussed and provided feedback. Discussed arbitration provision in LTC facility requirements proposed rule (OMB, CMS, HHS). Responded to inquiry on Virtual Caregiving Fair. PL 111-148 - Discussed ACA Medicaid HCBS spousal impoverishment provisions. Responded to inquiry on state nursing home legislation. Discussed Medicaid assisted living, HCBS setting rule and follow-up (GAO). Discussed Medicare home health (CMS). Urged support for family caregivers in Medicare and Medicaid and testing modeling. Signed letter to CMS regarding arbitration in LTC facility requirements rule. Discussed family caregiver assessment guidance (CMS). Attended PPI home health roundtable with staff from HHS. Responded to a question about a scorecard and letters to CMS. Responded to an inquiry regarding an arbitration regulatory provision. Responded to an inquiry regarding personal needs allowances. Discussed Medicaid functional assessment tools, family caregiver assessment, and follow-up(GAO). Responded to inquiries regarding Medicaid managed long-term services and supports, best practices, and state ombuds programs. S. 3130, Independence at Home Act - Discussed and sent AARP endorsement letter for bill

S. 3040, H.R. 5926, H.R. 5325,H.R. 2028, Labor, Health and Human Services Appropriations, FY2017 - Lobbied for funding support for various health and health care related programs serving seniors. S.3111, Seniors Tax Hike Prevention Act - Discussed medical expense deduction for the 65 plus population. Advocated on the issue of limited age rating for private health insurance. S. 3335, H.R. 6043, FAIR Drug Pricing Act - Supported bill. Discussed the Confidence in Long-Term Care Insurance Act (S. 159)/Long-Term Care Insurance Reform Act (H.R. 63) (bill numbers are in the 112th Congress). Discussed ACA repeal, Medicare, and Medicaid.

H.R.6 - Discussed the House Energy and Commerce Committee 21st Century Cures Initiative and Senate HELP Committee efforts focused on drug and medical device innovation issues. H.R. 3061, S. 31 - Discussed the importance of potential savings to both consumers and the federal government of granting Secretarial negotiating authority to the HHS Secretary under Medicare Part D. Discussed legislation to address pay-for-delay agreements used by drug manufacturers to block lower cost drugs from entering the market. Discussed the exclusivity period for biologic drugs. (no bill #) Discussed biologic drug issues including implementation of the new approval pathway for biosimilar drugs. Discussed other prescription drug issues and potential legislation on drug importation and least costly alternative payment for Part B drugs. (no bill #) Discussed the need for price transparency on prescription drug prices and comparativeness effectiveness research. Discussed legislation to address the opioid abuse epidemic including fraud and abuse provisions. Discussed opioid issues generally. (no bill #) H.R.9, S.1137 - Innovation Act, PATENT Act - Discussed patent reform legislation and related provisions on the Patent and Trademark Office inter partes review (IPR) process and proposed exemptions for brand name drug patents. Agriculture Appropriations, FY2017 - Lobbied in support of FDA funding. (no bill #)

H.R.6 - Discussed the House Energy and Commerce Committee 21st Century Cures Initiative and Senate HELP Committee efforts focused on drug and medical device innovation issues. S. 31, H.R. 3061 - Discussed the importance of potential savings to both consumers and the federal government of granting Secretarial negotiating authority to the HHS Secretary under Medicare Part D. S. 2019 - Discussed legislation to address pay-for-delay agreements used by drug manufacturers to block lower cost drugs from entering the market. S. 3094, H.R. 5573 - Discussed legislation to reduce the market exclusivity period for biologic drugs. Discussed biologic drug issues including implementation of the new approval pathway for biosimilar drugs. S. 3335, H.R. 6043 - Discussed the need for price transparency on prescription drug prices and comparativeness effectiveness research. Discussed legislation to address the opioid abuse epidemic including fraud and abuse provisions. Discussed opioid issues generally. S. 3056 - Discussed legislation to address abuse of Risk-Evaluation and Mitigation Strategies (REMS) by brand name drug companies to block lower-cost generic drugs from entering the market. S. 3455 - Discussed legislation to allow temporary importation authority in cases of drug shortages and non-competitive markets. S. 2956, H.R. 5054, H.R. 5325, Agriculture Appropriations, FY2017 - Lobbied in support of FDA funding. H.R. 6043, FAIR Drug Pricing Act - Supported bill to require manufactures of certain drugs and biological products to report to HHS price increases that result in a 10% or more increase in the price of a drug over a 12 month period.

H.R.6 - Discussed the House Energy and Commerce Committee 21st Century Cures Initiative and Senate HELP Committee efforts focused on drug and medical device innovation issues. S. 31, H.R. 3061 - Discussed the importance of potential savings to both consumers and the federal government of granting Secretarial negotiating authority to the HHS Secretary under Medicare Part D. S. 2019 - Discussed legislation to address pay-for-delay agreements used by drug manufacturers to block lower cost drugs from entering the market. S. 3094, H.R. 5573 - Discussed legislation to reduce the market exclusivity period for biologic drugs. Discussed biologic drug issues including implementation of the new approval pathway for biosimilar drugs. S. 3335, H.R. 6043 - Discussed the need for price transparency on prescription drug prices and comparativeness effectiveness research. Discussed legislation to address the opioid abuse epidemic including fraud and abuse provisions. Discussed opioid issues generally. S. 3056 - Discussed legislation to address abuse of Risk-Evaluation and Mitigation Strategies (REMS) by brand name drug companies to block lower-cost generic drugs from entering the market. S. 3455 - Discussed legislation to allow temporary importation authority in cases of drug shortages and non-competitive markets. S. 2956, H.R. 5054, H.R. 5325, H.R. 2028, Agriculture Appropriations, FY2017 - Lobbied in support of FDA funding. H.R. 6043, FAIR Drug Pricing Act - Supported bill to require manufactures of certain drugs and biological products to report to HHS price increases that result in a 10% or more increase in the price of a drug over a 12 month period.

H.R.6 - Discussed the House Energy and Commerce Committee 21st Century Cures Initiative and Senate HELP Committee efforts focused on drug and medical device innovation issues. S. 31, H.R. 3061 - Discussed the importance of potential savings to both consumers and the federal government of granting Secretarial negotiating authority to the HHS Secretary under Medicare Part D. Discussed legislation to address pay-for-delay agreements used by drug manufacturers to block lower cost drugs from entering the market. S. 3094, H.R. 5573 - Discussed the exclusivity period for biologic drugs. Discussed biologic drug issues including implementation of the new approval pathway for biosimilar drugs. Discussed the need for price transparency on prescription drug prices and comparativeness effectiveness research. Discussed legislation to address the opioid abuse epidemic including fraud and abuse provisions. Discussed opioid issues generally. S. 3056 - Discussed legislation to address abuse of Risk-Evaluation and Mitigation Strategies (REMS) by brand name drug companies to block lower-cost generic drugs from entering the market. S. 1137, H.R. 9, Innovation Act, PATENT Act - Discussed patent reform legislation and related provisions on the Patent and Trademark Office inter partes review (IPR) process and proposed exemptions for brand name drug patents. S. 2956, H.R. 5054, Agriculture Appropriations, FY2017 - Lobbied in support of FDA funding. Responded to inquiry regarding Medicare Part B demonstration.

H.R.6 - Discussed the House Energy and Commerce Committee 21st Century Cures Initiative and Senate HELP Committee efforts focused on drug and medical device innovation issues. S. 31, H.R. 3061 - Discussed the importance of potential savings to both consumers and the federal government of granting Secretarial negotiating authority to the HHS Secretary under Medicare Part D. S. 2019 - Discussed legislation to address pay-for-delay agreements used by drug manufacturers to block lower cost drugs from entering the market. S. 3094, H.R. 5573 - Discussed legislation to reduce the market exclusivity period for biologic drugs. Discussed biologic drug issues including implementation of the new approval pathway for biosimilar drugs. S. 3335, H.R. 6043 - Discussed the need for price transparency on prescription drug prices and comparativeness effectiveness research. Discussed legislation to address the opioid abuse epidemic including fraud and abuse provisions. Discussed opioid issues generally. S. 3056 - Discussed legislation to address abuse of Risk-Evaluation and Mitigation Strategies (REMS) by brand name drug companies to block lower-cost generic drugs from entering the market. S. 3455 - Discussed legislation to allow temporary importation authority in cases of drug shortages and non-competitive markets. S. 2956, H.R. 5054, H.R. 5325, H.R. 2028, Agriculture Appropriations, FY2017 - Lobbied in support of FDA funding. H.R. 6043, FAIR Drug Pricing Act - Supported bill to require manufactures of certain drugs and biological products to report to HHS price increases that result in a 10% or more increase in the price of a drug over a 12 month period.

H.R.6 - Discussed the House Energy and Commerce Committee 21st Century Cures Initiative and Senate HELP Committee efforts focused on drug and medical device innovation issues. S. 31, H.R. 3061 - Discussed the importance of potential savings to both consumers and the federal government of granting Secretarial negotiating authority to the HHS Secretary under Medicare Part D. S. 2019 - Discussed legislation to address pay-for-delay agreements used by drug manufacturers to block lower cost drugs from entering the market. S. 3094, H.R. 5573 - Discussed legislation to reduce the market exclusivity period for biologic drugs. Discussed biologic drug issues including implementation of the new approval pathway for biosimilar drugs. S. 3335, H.R. 6043 - Discussed the need for price transparency on prescription drug prices and comparativeness effectiveness research. Discussed legislation to address the opioid abuse epidemic including fraud and abuse provisions. Discussed opioid issues generally. S. 3056 - Discussed legislation to address abuse of Risk-Evaluation and Mitigation Strategies (REMS) by brand name drug companies to block lower-cost generic drugs from entering the market. S. 3455 - Discussed legislation to allow temporary importation authority in cases of drug shortages and non-competitive markets. S. 2956, H.R. 5054, H.R. 5325, Agriculture Appropriations, FY2017 - Lobbied in support of FDA funding. H.R. 6043, FAIR Drug Pricing Act - Supported bill to require manufactures of certain drugs and biological products to report to HHS price increases that result in a 10% or more increase in the price of a drug over a 12 month period.

S. 709, H.R. 1270, Restoring Access to Medication Act - Supported bill. H.R. 3590, Halt Tax Increases on the Middle Class and Seniors Act - Meetings, calls and emails urging support. Discussed the Fair Medical Billing Act. Discussed Medicare Advantage, Medicare Supplemental and employer health insurance. Discussed Affordable Care Act Medicaid expansion issues, including AARP comments on state 1115 waiver proposals to expand Medicaid. Discussed Medicare-Medicaid integration efforts and financial alignment demonstrations, other CMS demonstration initiatives. Discussed Older Americans Act home and community-based services program funding for FY2017. S. 2956, H.R. 5054 - Discussed nutrition programs including the Supplemental Nutrition Assistance Program (SNAP)and related changes under the 2014 farm bill. S. 3040, H.R. 5926, H.R. 5325, Labor, Health and Human Services Appropriations, FY2017 - Lobbied for funding support for various health and health care related programs serving seniors. S.3111, Seniors Tax Hike Prevention Act - Discussed medical expense deduction for the 65 plus population. Advocated on the issue of limited age rating for private health insurance. S. 3335, H.R. 6043, FAIR Drug Pricing Act - Supported bill.

S. 3040, H.R. 5926, H.R. 5325,H.R. 2028, Labor, Health and Human Services Appropriations, FY2017 - Lobbied for funding support for various health and health care related programs serving seniors. S.3111, Seniors Tax Hike Prevention Act - Discussed medical expense deduction for the 65 plus population. Advocated on the issue of limited age rating for private health insurance. S. 3335, H.R. 6043, FAIR Drug Pricing Act - Supported bill. Discussed the Confidence in Long-Term Care Insurance Act (S. 159)/Long-Term Care Insurance Reform Act (H.R. 63) (bill numbers are in the 112th Congress). Discussed ACA repeal, Medicare, and Medicaid.

H.R.6 - Discussed the House Energy and Commerce Committee 21st Century Cures Initiative and Senate HELP Committee efforts focused on drug and medical device innovation issues. S. 31, H.R. 3061 - Discussed the importance of potential savings to both consumers and the federal government of granting Secretarial negotiating authority to the HHS Secretary under Medicare Part D. Discussed legislation to address pay-for-delay agreements used by drug manufacturers to block lower cost drugs from entering the market. S. 3094, H.R. 5573 - Discussed the exclusivity period for biologic drugs. Discussed biologic drug issues including implementation of the new approval pathway for biosimilar drugs. Discussed the need for price transparency on prescription drug prices and comparativeness effectiveness research. Discussed legislation to address the opioid abuse epidemic including fraud and abuse provisions. Discussed opioid issues generally. S. 3056 - Discussed legislation to address abuse of Risk-Evaluation and Mitigation Strategies (REMS) by brand name drug companies to block lower-cost generic drugs from entering the market. S. 1137, H.R. 9, Innovation Act, PATENT Act - Discussed patent reform legislation and related provisions on the Patent and Trademark Office inter partes review (IPR) process and proposed exemptions for brand name drug patents. S. 2956, H.R. 5054, Agriculture Appropriations, FY2017 - Lobbied in support of FDA funding. Responded to inquiry regarding Medicare Part B demonstration.

H.R.6 - Discussed the House Energy and Commerce Committee 21st Century Cures Initiative and Senate HELP Committee efforts focused on drug and medical device innovation issues. H.R. 3061, S. 31 - Discussed the importance of potential savings to both consumers and the federal government of granting Secretarial negotiating authority to the HHS Secretary under Medicare Part D. Discussed legislation to address pay-for-delay agreements used by drug manufacturers to block lower cost drugs from entering the market. Discussed the exclusivity period for biologic drugs. (no bill #) Discussed biologic drug issues including implementation of the new approval pathway for biosimilar drugs. Discussed other prescription drug issues and potential legislation on drug importation and least costly alternative payment for Part B drugs. (no bill #) Discussed the need for price transparency on prescription drug prices and comparativeness effectiveness research. Discussed legislation to address the opioid abuse epidemic including fraud and abuse provisions. Discussed opioid issues generally. (no bill #) H.R.9, S.1137 - Innovation Act, PATENT Act - Discussed patent reform legislation and related provisions on the Patent and Trademark Office inter partes review (IPR) process and proposed exemptions for brand name drug patents. Agriculture Appropriations, FY2017 - Lobbied in support of FDA funding. (no bill #)

Discussed structural changes to Medicaid. Discussed health care quality and measurement. Discussed changes to the Medicare benefit design, such as copays, premiums and deductibles. S. 1083, H.R.2005 - Discussed legislation to require drug manufacturers to provide rebates for drugs provided to Medicare Part D low-income subsidy beneficiaries, including those who are dually eligible for Medicare and Medicaid. S. 1488, H.R. 2624, Part D Beneficiary Appeals Fairness Act - Discussed bill that would allow seniors to appeal the placement of their medications on a Medicare Part D specialty tier. Discussed Medicare Part D fraud and abuse legislation including lock-in provisions for high risk enrollees. Discussed legislation to require the addition of unique device identifier (UDI) of medical devices in health insurance claim forms. S. 624, H.R.1220, Removing Barriers to Colorectal Cancer Screening Act - Discussed bill. S. 3040, H.R. 5926, H.R. 5325, Labor, Health and Human Services Appropriations bill, FY2017 - Lobbied in support of increased funding for CMS' state survey and certification program. Discussed the Medicare Part D prescription drug benefit program and changes needed to lower prescription drug costs and related agency proposed rule changes. H.R. 5122 - Discussed the Medicare Part B prescription drug demonstration proposal from the Centers for Medicare and Medicaid Services. Discussed potential benefit and coverage improvements under Medicare and Medicare Savings Programs. Discussed Section 1115 Medicaid expansion demonstration waivers (HHS, CMS). H.R. 2759, Mental Health Access Improvement Act - Discussed support of bill. Discussed MACRA implementation. Discussed Medicare enrollment and coverage issues such as: provider access, direct billing and penalties. Discussed DOJ investigation regarding Olmstead and ADA violations by South Dakota (DOJ, ACL) and related public events. Discussed Olmstead enforcement and older adults at roundtable discussion. S. 3096, Removing Barriers to Person-Centered Care Act of 2016 - Discussed and provided feedback. Discussed possible hearing witnesses. Responded to inquiry regarding MACRA rules and value modifier. H.R. 3298, Post Acute Care Value Based Purchasing Act - Discussed and provided feedback. Discussed arbitration provision in LTC facility requirements proposed rule (OMB, CMS, HHS). Responded to inquiry on Virtual Caregiving Fair. PL 111-148 - Discussed ACA Medicaid HCBS spousal impoverishment provisions. Responded to inquiry on state nursing home legislation. Discussed Medicaid assisted living, HCBS setting rule and follow-up (GAO). Discussed Medicare home health (CMS). Urged support for family caregivers in Medicare and Medicaid and testing modeling. Signed letter to CMS regarding arbitration in LTC facility requirements rule. Discussed family caregiver assessment guidance (CMS). Attended PPI home health roundtable with staff from HHS. Responded to a question about a scorecard and letters to CMS. Responded to an inquiry regarding an arbitration regulatory provision. Responded to an inquiry regarding personal needs allowances. Discussed Medicaid functional assessment tools, family caregiver assessment, and follow-up(GAO). Responded to inquiries regarding Medicaid managed long-term services and supports, best practices, and state ombuds programs. S. 3130, Independence at Home Act - Discussed and sent AARP endorsement letter for bill

Responded to inquiry regarding in-home supportive services programs. (no bill #) S. 1549, Care Planning Act - Discussed the bill and urged cosponsorship. Discussed structural changes to Medicaid. (no bill #) Discussed health care quality and measurement. (no bill #) Discussed changes to the Medicare benefit design, such as copays, premiums and deductibles. (no bill #) Discussed Personalize Your Care Act and provided feedback. (no bill #) Discussed Money Follows the Person Rebalancing Demonstration. (no bill #) Made inquiry regarding DC Medicaid HCBS waiver. (no bill #) S. 1085, Military and Veteran Caregiver Services Improvement Act - Discussed bill. H.R. 4878, Better Care Lower Cost Act - Discussed bill. Discussed spousal impoverishment in Medicaid. (no bill #) H.R. 4059, S.2297, Medicare Choices Empowerment and Protection Act - Provided feedback on bill. H.R. 3298, Medicare Post-Acute Care Value-Based Purchasing Act - Discussed feedback and next steps. (no bill #) Inquired regarding final rule on discharge planning. (no bill #) H.R.1571, Improving Access to Medicare Coverage Act - Discussed bill. Discussed retroactive eligibility for Medicaid HCBS (no bill #) Discussed observations status issues. (no bill #) S.578, Home Health Planning Improvement Act - Discussed bill and urged cosponsorship. Discussed the Medicare Part D prescription drug benefit program and changes needed to lower prescription drug costs and related agency proposed rule changes. (no bill #) H.R.2005, S.1083 - Discussed legislation to require drug manufacturers to provide rebates for drugs provided to Medicare Part D low-income subsidy beneficiaries, including those who are dually eligible for Medicare and Medicaid. H.R. 2624, S.1488, Part D Beneficiary Appeals Fairness Act- Discussed bill that would allow seniors to appeal the placement of their medications on a Medicare Part D specialty tier. Discussed Medicare Part D fraud and abuse legislation including lock-in provisions for high risk enrollees. (no bill #) Discussed legislation to require the addition of unique device identifier (UDI) of medical devices in health insurance claim forms. Discussed the Medicare Part B prescription drug demonstration proposal from the Centers for Medicare and Medicaid Services. H.R.1220, S.624, Removing Barriers to Colorectal Cancer Screening Act - Discussed bill. Discussed Medicare site of service payment policy. (no bill #) H.R. 4442,S.2484,CONNECT Act - Sent letter of endorsement. Discussed Medicare coverage and reimbursement of cataract surgery. Labor, Health and Human Services,FY2017 - Lobbied in support of increased funding for CMS' state survey and certification program. (no bill #)

Responded to inquiry regarding in-home supportive services programs. S. 1549, Care Planning Act - Discussed the bill and urged cosponsorship. Discussed structural changes to Medicaid. Discussed health care quality and measurement. Discussed changes to the Medicare benefit design, such as copays, premiums and deductibles. H.R.1571, Improving Access to Medicare Coverage Act - Discussed bill. S.578, Home Health Planning Improvement Act - Discussed bill and urged cosponsorship. Discussed the Medicare Part D prescription drug benefit program and changes needed to lower prescription drug costs and related agency proposed rule changes. S. 1083, H.R.2005 - Discussed legislation to require drug manufacturers to provide rebates for drugs provided to Medicare Part D low-income subsidy beneficiaries, including those who are dually eligible for Medicare and Medicaid. S. 1488, H.R. 2624, Part D Beneficiary Appeals Fairness Act - Discussed bill that would allow seniors to appeal the placement of their medications on a Medicare Part D specialty tier. Discussed Medicare Part D fraud and abuse legislation including lock-in provisions for high risk enrollees. Discussed legislation to require the addition of unique device identifier (UDI) of medical devices in health insurance claim forms. Discussed the Medicare Part B prescription drug demonstration proposal from the Centers for Medicare and Medicaid Services. S. 624, H.R.1220,Removing Barriers to Colorectal Cancer Screening Act - Discussed bill. S. 3040, Labor, Health and Human Services,FY2017 - Lobbied in support of increased funding for CMS' state survey and certification program. S. 1549 - Discussed support of Care Planning Act. Discussed the Medicare Part B prescription drug benefit program and changes needed to lower prescription drug costs and related agency proposed rule changes. H.R. 5122 - Discussed the Medicare Part B prescription drug demonstration proposal. Discussed potential benefit and coverage improvements under Medicare and Medicaid Savings Programs. H.R. 2759, Mental Health Access Improvement Act - Discussed support of bill. Discussed MACRA implementation. Discussed Medicare enrollment and coverage issues such as: provider access, direct billing and penalties. S. 1719, H.R. 3099, RAISE Act - Discussed CMS' efforts regarding family caregiving. Provided feedback on advanced directive registry bill. (no bill #) Discussed independence at home legislation. S. 2961, Compassionate Care Act - Discussed our position and provided feedback. Discussed DOJ investigation regarding Olmstead and ADA violations by South Dakota and provided feedback (DOJ). Responded to inquiry regarding roundtable (ACL). S. 3096, Removing Barriers to Person-Centered Care Act of 2016 - Discussed and provided feedback. Discussed possible hearing witnesses. Discussed Medicaid HCBS spousal impoverishment bill. (no bill #) Responded to inquiry regarding MACRA rules and value modifier. Discussed Medicare's 180-day coverage of skilled nursing facility care. S. 2836, H.R. 5036, Protecting Families with Disabilities Act - Signed letter in support of bill.

Responded to inquiry regarding in-home supportive services programs. (no bill #) S. 1549, Care Planning Act - Discussed the bill and urged cosponsorship. Discussed structural changes to Medicaid. (no bill #) Discussed health care quality and measurement. (no bill #) Discussed changes to the Medicare benefit design, such as copays, premiums and deductibles. (no bill #) Discussed Personalize Your Care Act and provided feedback. (no bill #) Discussed Money Follows the Person Rebalancing Demonstration. (no bill #) Made inquiry regarding DC Medicaid HCBS waiver. (no bill #) S. 1085, Military and Veteran Caregiver Services Improvement Act - Discussed bill. H.R. 4878, Better Care Lower Cost Act - Discussed bill. Discussed spousal impoverishment in Medicaid. (no bill #) H.R. 4059, S.2297, Medicare Choices Empowerment and Protection Act - Provided feedback on bill. H.R. 3298, Medicare Post-Acute Care Value-Based Purchasing Act - Discussed feedback and next steps. (no bill #) Inquired regarding final rule on discharge planning. (no bill #) H.R.1571, Improving Access to Medicare Coverage Act - Discussed bill. Discussed retroactive eligibility for Medicaid HCBS (no bill #) Discussed observations status issues. (no bill #) S.578, Home Health Planning Improvement Act - Discussed bill and urged cosponsorship. Discussed the Medicare Part D prescription drug benefit program and changes needed to lower prescription drug costs and related agency proposed rule changes. (no bill #) H.R.2005, S.1083 - Discussed legislation to require drug manufacturers to provide rebates for drugs provided to Medicare Part D low-income subsidy beneficiaries, including those who are dually eligible for Medicare and Medicaid. H.R. 2624, S.1488, Part D Beneficiary Appeals Fairness Act- Discussed bill that would allow seniors to appeal the placement of their medications on a Medicare Part D specialty tier. Discussed Medicare Part D fraud and abuse legislation including lock-in provisions for high risk enrollees. (no bill #) Discussed legislation to require the addition of unique device identifier (UDI) of medical devices in health insurance claim forms. Discussed the Medicare Part B prescription drug demonstration proposal from the Centers for Medicare and Medicaid Services. H.R.1220, S.624, Removing Barriers to Colorectal Cancer Screening Act - Discussed bill. Discussed Medicare site of service payment policy. (no bill #) H.R. 4442,S.2484,CONNECT Act - Sent letter of endorsement. Discussed Medicare coverage and reimbursement of cataract surgery. Labor, Health and Human Services,FY2017 - Lobbied in support of increased funding for CMS' state survey and certification program. (no bill #)

H.R.6 - Discussed the House Energy and Commerce Committee 21st Century Cures Initiative and Senate HELP Committee efforts focused on drug and medical device innovation issues. S. 31, H.R. 3061 - Discussed the importance of potential savings to both consumers and the federal government of granting Secretarial negotiating authority to the HHS Secretary under Medicare Part D. Discussed legislation to address pay-for-delay agreements used by drug manufacturers to block lower cost drugs from entering the market. S. 3094, H.R. 5573 - Discussed the exclusivity period for biologic drugs. Discussed biologic drug issues including implementation of the new approval pathway for biosimilar drugs. Discussed the need for price transparency on prescription drug prices and comparativeness effectiveness research. Discussed legislation to address the opioid abuse epidemic including fraud and abuse provisions. Discussed opioid issues generally. S. 3056 - Discussed legislation to address abuse of Risk-Evaluation and Mitigation Strategies (REMS) by brand name drug companies to block lower-cost generic drugs from entering the market. S. 1137, H.R. 9, Innovation Act, PATENT Act - Discussed patent reform legislation and related provisions on the Patent and Trademark Office inter partes review (IPR) process and proposed exemptions for brand name drug patents. S. 2956, H.R. 5054, Agriculture Appropriations, FY2017 - Lobbied in support of FDA funding. Responded to inquiry regarding Medicare Part B demonstration.

H.R.6 - Discussed the House Energy and Commerce Committee 21st Century Cures Initiative and Senate HELP Committee efforts focused on drug and medical device innovation issues. H.R. 3061, S. 31 - Discussed the importance of potential savings to both consumers and the federal government of granting Secretarial negotiating authority to the HHS Secretary under Medicare Part D. Discussed legislation to address pay-for-delay agreements used by drug manufacturers to block lower cost drugs from entering the market. Discussed the exclusivity period for biologic drugs. (no bill #) Discussed biologic drug issues including implementation of the new approval pathway for biosimilar drugs. Discussed other prescription drug issues and potential legislation on drug importation and least costly alternative payment for Part B drugs. (no bill #) Discussed the need for price transparency on prescription drug prices and comparativeness effectiveness research. Discussed legislation to address the opioid abuse epidemic including fraud and abuse provisions. Discussed opioid issues generally. (no bill #) H.R.9, S.1137 - Innovation Act, PATENT Act - Discussed patent reform legislation and related provisions on the Patent and Trademark Office inter partes review (IPR) process and proposed exemptions for brand name drug patents. Agriculture Appropriations, FY2017 - Lobbied in support of FDA funding. (no bill #)

Responded to inquiry regarding in-home supportive services programs. (no bill #) S. 1549, Care Planning Act - Discussed the bill and urged cosponsorship. Discussed structural changes to Medicaid. (no bill #) Discussed health care quality and measurement. (no bill #) Discussed changes to the Medicare benefit design, such as copays, premiums and deductibles. (no bill #) Discussed Personalize Your Care Act and provided feedback. (no bill #) Discussed Money Follows the Person Rebalancing Demonstration. (no bill #) Made inquiry regarding DC Medicaid HCBS waiver. (no bill #) S. 1085, Military and Veteran Caregiver Services Improvement Act - Discussed bill. H.R. 4878, Better Care Lower Cost Act - Discussed bill. Discussed spousal impoverishment in Medicaid. (no bill #) H.R. 4059, S.2297, Medicare Choices Empowerment and Protection Act - Provided feedback on bill. H.R. 3298, Medicare Post-Acute Care Value-Based Purchasing Act - Discussed feedback and next steps. (no bill #) Inquired regarding final rule on discharge planning. (no bill #) H.R.1571, Improving Access to Medicare Coverage Act - Discussed bill. Discussed retroactive eligibility for Medicaid HCBS (no bill #) Discussed observations status issues. (no bill #) S.578, Home Health Planning Improvement Act - Discussed bill and urged cosponsorship. Discussed the Medicare Part D prescription drug benefit program and changes needed to lower prescription drug costs and related agency proposed rule changes. (no bill #) H.R.2005, S.1083 - Discussed legislation to require drug manufacturers to provide rebates for drugs provided to Medicare Part D low-income subsidy beneficiaries, including those who are dually eligible for Medicare and Medicaid. H.R. 2624, S.1488, Part D Beneficiary Appeals Fairness Act- Discussed bill that would allow seniors to appeal the placement of their medications on a Medicare Part D specialty tier. Discussed Medicare Part D fraud and abuse legislation including lock-in provisions for high risk enrollees. (no bill #) Discussed legislation to require the addition of unique device identifier (UDI) of medical devices in health insurance claim forms. Discussed the Medicare Part B prescription drug demonstration proposal from the Centers for Medicare and Medicaid Services. H.R.1220, S.624, Removing Barriers to Colorectal Cancer Screening Act - Discussed bill. Discussed Medicare site of service payment policy. (no bill #) H.R. 4442,S.2484,CONNECT Act - Sent letter of endorsement. Discussed Medicare coverage and reimbursement of cataract surgery. Labor, Health and Human Services,FY2017 - Lobbied in support of increased funding for CMS' state survey and certification program. (no bill #)

Responded to inquiry regarding in-home supportive services programs. S. 1549, Care Planning Act - Discussed the bill and urged cosponsorship. Discussed structural changes to Medicaid. Discussed health care quality and measurement. Discussed changes to the Medicare benefit design, such as copays, premiums and deductibles. H.R.1571, Improving Access to Medicare Coverage Act - Discussed bill. S.578, Home Health Planning Improvement Act - Discussed bill and urged cosponsorship. Discussed the Medicare Part D prescription drug benefit program and changes needed to lower prescription drug costs and related agency proposed rule changes. S. 1083, H.R.2005 - Discussed legislation to require drug manufacturers to provide rebates for drugs provided to Medicare Part D low-income subsidy beneficiaries, including those who are dually eligible for Medicare and Medicaid. S. 1488, H.R. 2624, Part D Beneficiary Appeals Fairness Act - Discussed bill that would allow seniors to appeal the placement of their medications on a Medicare Part D specialty tier. Discussed Medicare Part D fraud and abuse legislation including lock-in provisions for high risk enrollees. Discussed legislation to require the addition of unique device identifier (UDI) of medical devices in health insurance claim forms. Discussed the Medicare Part B prescription drug demonstration proposal from the Centers for Medicare and Medicaid Services. S. 624, H.R.1220,Removing Barriers to Colorectal Cancer Screening Act - Discussed bill. S. 3040, Labor, Health and Human Services,FY2017 - Lobbied in support of increased funding for CMS' state survey and certification program. S. 1549 - Discussed support of Care Planning Act. Discussed the Medicare Part B prescription drug benefit program and changes needed to lower prescription drug costs and related agency proposed rule changes. H.R. 5122 - Discussed the Medicare Part B prescription drug demonstration proposal. Discussed potential benefit and coverage improvements under Medicare and Medicaid Savings Programs. H.R. 2759, Mental Health Access Improvement Act - Discussed support of bill. Discussed MACRA implementation. Discussed Medicare enrollment and coverage issues such as: provider access, direct billing and penalties. S. 1719, H.R. 3099, RAISE Act - Discussed CMS' efforts regarding family caregiving. Provided feedback on advanced directive registry bill. (no bill #) Discussed independence at home legislation. S. 2961, Compassionate Care Act - Discussed our position and provided feedback. Discussed DOJ investigation regarding Olmstead and ADA violations by South Dakota and provided feedback (DOJ). Responded to inquiry regarding roundtable (ACL). S. 3096, Removing Barriers to Person-Centered Care Act of 2016 - Discussed and provided feedback. Discussed possible hearing witnesses. Discussed Medicaid HCBS spousal impoverishment bill. (no bill #) Responded to inquiry regarding MACRA rules and value modifier. Discussed Medicare's 180-day coverage of skilled nursing facility care. S. 2836, H.R. 5036, Protecting Families with Disabilities Act - Signed letter in support of bill.

Discussed structural changes to Medicaid. Discussed health care quality and measurement. Discussed changes to the Medicare benefit design, such as copays, premiums and deductibles. S. 1083, H.R.2005 - Discussed legislation to require drug manufacturers to provide rebates for drugs provided to Medicare Part D low-income subsidy beneficiaries, including those who are dually eligible for Medicare and Medicaid. S. 1488, H.R. 2624, Part D Beneficiary Appeals Fairness Act - Discussed bill that would allow seniors to appeal the placement of their medications on a Medicare Part D specialty tier. Discussed Medicare Part D fraud and abuse legislation including lock-in provisions for high risk enrollees. Discussed legislation to require the addition of unique device identifier (UDI) of medical devices in health insurance claim forms. S. 624, H.R.1220, Removing Barriers to Colorectal Cancer Screening Act - Discussed bill. S. 3040, H.R. 5926, H.R. 5325, Labor, Health and Human Services Appropriations bill, FY2017 - Lobbied in support of increased funding for CMS' state survey and certification program. Discussed the Medicare Part D prescription drug benefit program and changes needed to lower prescription drug costs and related agency proposed rule changes. H.R. 5122 - Discussed the Medicare Part B prescription drug demonstration proposal from the Centers for Medicare and Medicaid Services. Discussed potential benefit and coverage improvements under Medicare and Medicare Savings Programs. Discussed Section 1115 Medicaid expansion demonstration waivers (HHS, CMS). H.R. 2759, Mental Health Access Improvement Act - Discussed support of bill. Discussed MACRA implementation. Discussed Medicare enrollment and coverage issues such as: provider access, direct billing and penalties. Discussed DOJ investigation regarding Olmstead and ADA violations by South Dakota (DOJ, ACL) and related public events. Discussed Olmstead enforcement and older adults at roundtable discussion. S. 3096, Removing Barriers to Person-Centered Care Act of 2016 - Discussed and provided feedback. Discussed possible hearing witnesses. Responded to inquiry regarding MACRA rules and value modifier. H.R. 3298, Post Acute Care Value Based Purchasing Act - Discussed and provided feedback. Discussed arbitration provision in LTC facility requirements proposed rule (OMB, CMS, HHS). Responded to inquiry on Virtual Caregiving Fair. PL 111-148 - Discussed ACA Medicaid HCBS spousal impoverishment provisions. Responded to inquiry on state nursing home legislation. Discussed Medicaid assisted living, HCBS setting rule and follow-up (GAO). Discussed Medicare home health (CMS). Urged support for family caregivers in Medicare and Medicaid and testing modeling. Signed letter to CMS regarding arbitration in LTC facility requirements rule. Discussed family caregiver assessment guidance (CMS). Attended PPI home health roundtable with staff from HHS. Responded to a question about a scorecard and letters to CMS. Responded to an inquiry regarding an arbitration regulatory provision. Responded to an inquiry regarding personal needs allowances. Discussed Medicaid functional assessment tools, family caregiver assessment, and follow-up(GAO). Responded to inquiries regarding Medicaid managed long-term services and supports, best practices, and state ombuds programs. S. 3130, Independence at Home Act - Discussed and sent AARP endorsement letter for bill

Responded to inquiry regarding in-home supportive services programs. (no bill #) S. 1549, Care Planning Act - Discussed the bill and urged cosponsorship. Discussed structural changes to Medicaid. (no bill #) Discussed health care quality and measurement. (no bill #) Discussed changes to the Medicare benefit design, such as copays, premiums and deductibles. (no bill #) Discussed Personalize Your Care Act and provided feedback. (no bill #) Discussed Money Follows the Person Rebalancing Demonstration. (no bill #) Made inquiry regarding DC Medicaid HCBS waiver. (no bill #) S. 1085, Military and Veteran Caregiver Services Improvement Act - Discussed bill. H.R. 4878, Better Care Lower Cost Act - Discussed bill. Discussed spousal impoverishment in Medicaid. (no bill #) H.R. 4059, S.2297, Medicare Choices Empowerment and Protection Act - Provided feedback on bill. H.R. 3298, Medicare Post-Acute Care Value-Based Purchasing Act - Discussed feedback and next steps. (no bill #) Inquired regarding final rule on discharge planning. (no bill #) H.R.1571, Improving Access to Medicare Coverage Act - Discussed bill. Discussed retroactive eligibility for Medicaid HCBS (no bill #) Discussed observations status issues. (no bill #) S.578, Home Health Planning Improvement Act - Discussed bill and urged cosponsorship. Discussed the Medicare Part D prescription drug benefit program and changes needed to lower prescription drug costs and related agency proposed rule changes. (no bill #) H.R.2005, S.1083 - Discussed legislation to require drug manufacturers to provide rebates for drugs provided to Medicare Part D low-income subsidy beneficiaries, including those who are dually eligible for Medicare and Medicaid. H.R. 2624, S.1488, Part D Beneficiary Appeals Fairness Act- Discussed bill that would allow seniors to appeal the placement of their medications on a Medicare Part D specialty tier. Discussed Medicare Part D fraud and abuse legislation including lock-in provisions for high risk enrollees. (no bill #) Discussed legislation to require the addition of unique device identifier (UDI) of medical devices in health insurance claim forms. Discussed the Medicare Part B prescription drug demonstration proposal from the Centers for Medicare and Medicaid Services. H.R.1220, S.624, Removing Barriers to Colorectal Cancer Screening Act - Discussed bill. Discussed Medicare site of service payment policy. (no bill #) H.R. 4442,S.2484,CONNECT Act - Sent letter of endorsement. Discussed Medicare coverage and reimbursement of cataract surgery. Labor, Health and Human Services,FY2017 - Lobbied in support of increased funding for CMS' state survey and certification program. (no bill #)

Responded to inquiry regarding in-home supportive services programs. S. 1549, Care Planning Act - Discussed the bill and urged cosponsorship. Discussed structural changes to Medicaid. Discussed health care quality and measurement. Discussed changes to the Medicare benefit design, such as copays, premiums and deductibles. H.R.1571, Improving Access to Medicare Coverage Act - Discussed bill. S.578, Home Health Planning Improvement Act - Discussed bill and urged cosponsorship. Discussed the Medicare Part D prescription drug benefit program and changes needed to lower prescription drug costs and related agency proposed rule changes. S. 1083, H.R.2005 - Discussed legislation to require drug manufacturers to provide rebates for drugs provided to Medicare Part D low-income subsidy beneficiaries, including those who are dually eligible for Medicare and Medicaid. S. 1488, H.R. 2624, Part D Beneficiary Appeals Fairness Act - Discussed bill that would allow seniors to appeal the placement of their medications on a Medicare Part D specialty tier. Discussed Medicare Part D fraud and abuse legislation including lock-in provisions for high risk enrollees. Discussed legislation to require the addition of unique device identifier (UDI) of medical devices in health insurance claim forms. Discussed the Medicare Part B prescription drug demonstration proposal from the Centers for Medicare and Medicaid Services. S. 624, H.R.1220,Removing Barriers to Colorectal Cancer Screening Act - Discussed bill. S. 3040, Labor, Health and Human Services,FY2017 - Lobbied in support of increased funding for CMS' state survey and certification program. S. 1549 - Discussed support of Care Planning Act. Discussed the Medicare Part B prescription drug benefit program and changes needed to lower prescription drug costs and related agency proposed rule changes. H.R. 5122 - Discussed the Medicare Part B prescription drug demonstration proposal. Discussed potential benefit and coverage improvements under Medicare and Medicaid Savings Programs. H.R. 2759, Mental Health Access Improvement Act - Discussed support of bill. Discussed MACRA implementation. Discussed Medicare enrollment and coverage issues such as: provider access, direct billing and penalties. S. 1719, H.R. 3099, RAISE Act - Discussed CMS' efforts regarding family caregiving. Provided feedback on advanced directive registry bill. (no bill #) Discussed independence at home legislation. S. 2961, Compassionate Care Act - Discussed our position and provided feedback. Discussed DOJ investigation regarding Olmstead and ADA violations by South Dakota and provided feedback (DOJ). Responded to inquiry regarding roundtable (ACL). S. 3096, Removing Barriers to Person-Centered Care Act of 2016 - Discussed and provided feedback. Discussed possible hearing witnesses. Discussed Medicaid HCBS spousal impoverishment bill. (no bill #) Responded to inquiry regarding MACRA rules and value modifier. Discussed Medicare's 180-day coverage of skilled nursing facility care. S. 2836, H.R. 5036, Protecting Families with Disabilities Act - Signed letter in support of bill.

Responded to inquiry regarding in-home supportive services programs. S. 1549, Care Planning Act - Discussed the bill and urged cosponsorship. Discussed structural changes to Medicaid. Discussed health care quality and measurement. Discussed changes to the Medicare benefit design, such as copays, premiums and deductibles. H.R.1571, Improving Access to Medicare Coverage Act - Discussed bill. S.578, Home Health Planning Improvement Act - Discussed bill and urged cosponsorship. Discussed the Medicare Part D prescription drug benefit program and changes needed to lower prescription drug costs and related agency proposed rule changes. S. 1083, H.R.2005 - Discussed legislation to require drug manufacturers to provide rebates for drugs provided to Medicare Part D low-income subsidy beneficiaries, including those who are dually eligible for Medicare and Medicaid. S. 1488, H.R. 2624, Part D Beneficiary Appeals Fairness Act - Discussed bill that would allow seniors to appeal the placement of their medications on a Medicare Part D specialty tier. Discussed Medicare Part D fraud and abuse legislation including lock-in provisions for high risk enrollees. Discussed legislation to require the addition of unique device identifier (UDI) of medical devices in health insurance claim forms. Discussed the Medicare Part B prescription drug demonstration proposal from the Centers for Medicare and Medicaid Services. S. 624, H.R.1220,Removing Barriers to Colorectal Cancer Screening Act - Discussed bill. S. 3040, Labor, Health and Human Services,FY2017 - Lobbied in support of increased funding for CMS' state survey and certification program. S. 1549 - Discussed support of Care Planning Act. Discussed the Medicare Part B prescription drug benefit program and changes needed to lower prescription drug costs and related agency proposed rule changes. H.R. 5122 - Discussed the Medicare Part B prescription drug demonstration proposal. Discussed potential benefit and coverage improvements under Medicare and Medicaid Savings Programs. H.R. 2759, Mental Health Access Improvement Act - Discussed support of bill. Discussed MACRA implementation. Discussed Medicare enrollment and coverage issues such as: provider access, direct billing and penalties. S. 1719, H.R. 3099, RAISE Act - Discussed CMS' efforts regarding family caregiving. Provided feedback on advanced directive registry bill. (no bill #) Discussed independence at home legislation. S. 2961, Compassionate Care Act - Discussed our position and provided feedback. Discussed DOJ investigation regarding Olmstead and ADA violations by South Dakota and provided feedback (DOJ). Responded to inquiry regarding roundtable (ACL). S. 3096, Removing Barriers to Person-Centered Care Act of 2016 - Discussed and provided feedback. Discussed possible hearing witnesses. Discussed Medicaid HCBS spousal impoverishment bill. (no bill #) Responded to inquiry regarding MACRA rules and value modifier. Discussed Medicare's 180-day coverage of skilled nursing facility care. S. 2836, H.R. 5036, Protecting Families with Disabilities Act - Signed letter in support of bill.

Responded to inquiry regarding in-home supportive services programs. S. 1549, Care Planning Act - Discussed the bill and urged cosponsorship. Discussed structural changes to Medicaid. Discussed health care quality and measurement. Discussed changes to the Medicare benefit design, such as copays, premiums and deductibles. H.R.1571, Improving Access to Medicare Coverage Act - Discussed bill. S.578, Home Health Planning Improvement Act - Discussed bill and urged cosponsorship. Discussed the Medicare Part D prescription drug benefit program and changes needed to lower prescription drug costs and related agency proposed rule changes. S. 1083, H.R.2005 - Discussed legislation to require drug manufacturers to provide rebates for drugs provided to Medicare Part D low-income subsidy beneficiaries, including those who are dually eligible for Medicare and Medicaid. S. 1488, H.R. 2624, Part D Beneficiary Appeals Fairness Act - Discussed bill that would allow seniors to appeal the placement of their medications on a Medicare Part D specialty tier. Discussed Medicare Part D fraud and abuse legislation including lock-in provisions for high risk enrollees. Discussed legislation to require the addition of unique device identifier (UDI) of medical devices in health insurance claim forms. Discussed the Medicare Part B prescription drug demonstration proposal from the Centers for Medicare and Medicaid Services. S. 624, H.R.1220,Removing Barriers to Colorectal Cancer Screening Act - Discussed bill. S. 3040, Labor, Health and Human Services,FY2017 - Lobbied in support of increased funding for CMS' state survey and certification program. S. 1549 - Discussed support of Care Planning Act. Discussed the Medicare Part B prescription drug benefit program and changes needed to lower prescription drug costs and related agency proposed rule changes. H.R. 5122 - Discussed the Medicare Part B prescription drug demonstration proposal. Discussed potential benefit and coverage improvements under Medicare and Medicaid Savings Programs. H.R. 2759, Mental Health Access Improvement Act - Discussed support of bill. Discussed MACRA implementation. Discussed Medicare enrollment and coverage issues such as: provider access, direct billing and penalties. S. 1719, H.R. 3099, RAISE Act - Discussed CMS' efforts regarding family caregiving. Provided feedback on advanced directive registry bill. (no bill #) Discussed independence at home legislation. S. 2961, Compassionate Care Act - Discussed our position and provided feedback. Discussed DOJ investigation regarding Olmstead and ADA violations by South Dakota and provided feedback (DOJ). Responded to inquiry regarding roundtable (ACL). S. 3096, Removing Barriers to Person-Centered Care Act of 2016 - Discussed and provided feedback. Discussed possible hearing witnesses. Discussed Medicaid HCBS spousal impoverishment bill. (no bill #) Responded to inquiry regarding MACRA rules and value modifier. Discussed Medicare's 180-day coverage of skilled nursing facility care. S. 2836, H.R. 5036, Protecting Families with Disabilities Act - Signed letter in support of bill.

H.R. 1270, S.709, Restoring Access to Medication Act - Meetings, calls and emails urging support. H.R. 3590 - Halt Tax Increases on the Middle Class and Seniors Act - Meetings, calls and emails urging support. Lobbied the Centers for Medicare and Medicaid Services on the 2017 Medicare Advantage Advance Notice and Medicare Part D Call Letter. Discussed the Fair Medical Billing Act. (no bill #) Discussed Medicare Advantage, Medicare Supplemental and employer health insurance. Discussed Global Council on Brain Health, brain health generally and Alzheimer's. (no bill #) S. 192, Older Americans Act - Discussed reauthorization and urged congressional offices to sign letter of support. Discussed Affordable Care Act Medicaid expansion issues, including AARP comments on state 1115 waiver proposals to expand Medicaid. Discussed Medicare-Medicaid integration efforts and financial alignment demonstrations, other CMS demonstration initiatives. (no bill #) Discussed Older Americans Act home and community-based services program funding for FY2017. Discussed nutrition programs including the Supplemental Nutrition Assistance Program (SNAP)and related changes under the 2014 farm bill. H.R.1220, S.624, Removing Barriers to Colorectal Cancer Screening Act - Discussed bill. Labor, Health and Human Services Appropriations, FY2017 - Lobbied for funding support for various health and health care related programs serving seniors. (no bill #)

S. 709, H.R. 1270,Restoring Access to Medication Act - Meetings, calls and emails urging support. H.R. 3590 - Halt Tax Increases on the Middle Class and Seniors Act - Meetings, calls and emails urging support. Discussed the Fair Medical Billing Act. (no bill #) Discussed Medicare Advantage, Medicare Supplemental and employer health insurance. S. 192, Older Americans Act - Discussed reauthorization. Discussed Affordable Care Act Medicaid expansion issues, including AARP comments on state 1115 waiver proposals to expand Medicaid. Discussed Medicare-Medicaid integration efforts and financial alignment demonstrations, other CMS demonstration initiatives. Discussed Older Americans Act home and community-based services program funding for FY2017. S. 2956, H.R. 5054 - Discussed nutrition programs including the Supplemental Nutrition Assistance Program (SNAP)and related changes under the 2014 farm bill. S. 624, H.R.1220, Removing Barriers to Colorectal Cancer Screening Act - Discussed bill. S. 3040, Labor, Health and Human Services Appropriations, FY2017 - Lobbied for funding support for various health and health care related programs serving seniors. (no bill #) S.311, Seniors Tax Hike Prevention Act - Discussed medical expense deduction for the 65 plus population. Advocated on the issue of limited age rating for private health insurance. Advocated on the medical expense tax deduction. Shared comment letters on SNAP with Agriculture Committee staff.

H.R.6 - Discussed the House Energy and Commerce Committee 21st Century Cures Initiative and Senate HELP Committee efforts focused on drug and medical device innovation issues. S. 31, H.R. 3061 - Discussed the importance of potential savings to both consumers and the federal government of granting Secretarial negotiating authority to the HHS Secretary under Medicare Part D. S. 2019 - Discussed legislation to address pay-for-delay agreements used by drug manufacturers to block lower cost drugs from entering the market. S. 3094, H.R. 5573 - Discussed legislation to reduce the market exclusivity period for biologic drugs. Discussed biologic drug issues including implementation of the new approval pathway for biosimilar drugs. S. 3335, H.R. 6043 - Discussed the need for price transparency on prescription drug prices and comparativeness effectiveness research. Discussed legislation to address the opioid abuse epidemic including fraud and abuse provisions. Discussed opioid issues generally. S. 3056 - Discussed legislation to address abuse of Risk-Evaluation and Mitigation Strategies (REMS) by brand name drug companies to block lower-cost generic drugs from entering the market. S. 3455 - Discussed legislation to allow temporary importation authority in cases of drug shortages and non-competitive markets. S. 2956, H.R. 5054, H.R. 5325, H.R. 2028, Agriculture Appropriations, FY2017 - Lobbied in support of FDA funding. H.R. 6043, FAIR Drug Pricing Act - Supported bill to require manufactures of certain drugs and biological products to report to HHS price increases that result in a 10% or more increase in the price of a drug over a 12 month period.

H.R.6 - Discussed the House Energy and Commerce Committee 21st Century Cures Initiative and Senate HELP Committee efforts focused on drug and medical device innovation issues. S. 31, H.R. 3061 - Discussed the importance of potential savings to both consumers and the federal government of granting Secretarial negotiating authority to the HHS Secretary under Medicare Part D. S. 2019 - Discussed legislation to address pay-for-delay agreements used by drug manufacturers to block lower cost drugs from entering the market. S. 3094, H.R. 5573 - Discussed legislation to reduce the market exclusivity period for biologic drugs. Discussed biologic drug issues including implementation of the new approval pathway for biosimilar drugs. S. 3335, H.R. 6043 - Discussed the need for price transparency on prescription drug prices and comparativeness effectiveness research. Discussed legislation to address the opioid abuse epidemic including fraud and abuse provisions. Discussed opioid issues generally. S. 3056 - Discussed legislation to address abuse of Risk-Evaluation and Mitigation Strategies (REMS) by brand name drug companies to block lower-cost generic drugs from entering the market. S. 3455 - Discussed legislation to allow temporary importation authority in cases of drug shortages and non-competitive markets. S. 2956, H.R. 5054, H.R. 5325, Agriculture Appropriations, FY2017 - Lobbied in support of FDA funding. H.R. 6043, FAIR Drug Pricing Act - Supported bill to require manufactures of certain drugs and biological products to report to HHS price increases that result in a 10% or more increase in the price of a drug over a 12 month period.

Responded to inquiry regarding in-home supportive services programs. (no bill #) S. 1549, Care Planning Act - Discussed the bill and urged cosponsorship. Discussed structural changes to Medicaid. (no bill #) Discussed health care quality and measurement. (no bill #) Discussed changes to the Medicare benefit design, such as copays, premiums and deductibles. (no bill #) Discussed Personalize Your Care Act and provided feedback. (no bill #) Discussed Money Follows the Person Rebalancing Demonstration. (no bill #) Made inquiry regarding DC Medicaid HCBS waiver. (no bill #) S. 1085, Military and Veteran Caregiver Services Improvement Act - Discussed bill. H.R. 4878, Better Care Lower Cost Act - Discussed bill. Discussed spousal impoverishment in Medicaid. (no bill #) H.R. 4059, S.2297, Medicare Choices Empowerment and Protection Act - Provided feedback on bill. H.R. 3298, Medicare Post-Acute Care Value-Based Purchasing Act - Discussed feedback and next steps. (no bill #) Inquired regarding final rule on discharge planning. (no bill #) H.R.1571, Improving Access to Medicare Coverage Act - Discussed bill. Discussed retroactive eligibility for Medicaid HCBS (no bill #) Discussed observations status issues. (no bill #) S.578, Home Health Planning Improvement Act - Discussed bill and urged cosponsorship. Discussed the Medicare Part D prescription drug benefit program and changes needed to lower prescription drug costs and related agency proposed rule changes. (no bill #) H.R.2005, S.1083 - Discussed legislation to require drug manufacturers to provide rebates for drugs provided to Medicare Part D low-income subsidy beneficiaries, including those who are dually eligible for Medicare and Medicaid. H.R. 2624, S.1488, Part D Beneficiary Appeals Fairness Act- Discussed bill that would allow seniors to appeal the placement of their medications on a Medicare Part D specialty tier. Discussed Medicare Part D fraud and abuse legislation including lock-in provisions for high risk enrollees. (no bill #) Discussed legislation to require the addition of unique device identifier (UDI) of medical devices in health insurance claim forms. Discussed the Medicare Part B prescription drug demonstration proposal from the Centers for Medicare and Medicaid Services. H.R.1220, S.624, Removing Barriers to Colorectal Cancer Screening Act - Discussed bill. Discussed Medicare site of service payment policy. (no bill #) H.R. 4442,S.2484,CONNECT Act - Sent letter of endorsement. Discussed Medicare coverage and reimbursement of cataract surgery. Labor, Health and Human Services,FY2017 - Lobbied in support of increased funding for CMS' state survey and certification program. (no bill #)

Responded to inquiry regarding in-home supportive services programs. (no bill #) S. 1549, Care Planning Act - Discussed the bill and urged cosponsorship. Discussed structural changes to Medicaid. (no bill #) Discussed health care quality and measurement. (no bill #) Discussed changes to the Medicare benefit design, such as copays, premiums and deductibles. (no bill #) Discussed Personalize Your Care Act and provided feedback. (no bill #) Discussed Money Follows the Person Rebalancing Demonstration. (no bill #) Made inquiry regarding DC Medicaid HCBS waiver. (no bill #) S. 1085, Military and Veteran Caregiver Services Improvement Act - Discussed bill. H.R. 4878, Better Care Lower Cost Act - Discussed bill. Discussed spousal impoverishment in Medicaid. (no bill #) H.R. 4059, S.2297, Medicare Choices Empowerment and Protection Act - Provided feedback on bill. H.R. 3298, Medicare Post-Acute Care Value-Based Purchasing Act - Discussed feedback and next steps. (no bill #) Inquired regarding final rule on discharge planning. (no bill #) H.R.1571, Improving Access to Medicare Coverage Act - Discussed bill. Discussed retroactive eligibility for Medicaid HCBS (no bill #) Discussed observations status issues. (no bill #) S.578, Home Health Planning Improvement Act - Discussed bill and urged cosponsorship. Discussed the Medicare Part D prescription drug benefit program and changes needed to lower prescription drug costs and related agency proposed rule changes. (no bill #) H.R.2005, S.1083 - Discussed legislation to require drug manufacturers to provide rebates for drugs provided to Medicare Part D low-income subsidy beneficiaries, including those who are dually eligible for Medicare and Medicaid. H.R. 2624, S.1488, Part D Beneficiary Appeals Fairness Act- Discussed bill that would allow seniors to appeal the placement of their medications on a Medicare Part D specialty tier. Discussed Medicare Part D fraud and abuse legislation including lock-in provisions for high risk enrollees. (no bill #) Discussed legislation to require the addition of unique device identifier (UDI) of medical devices in health insurance claim forms. Discussed the Medicare Part B prescription drug demonstration proposal from the Centers for Medicare and Medicaid Services. H.R.1220, S.624, Removing Barriers to Colorectal Cancer Screening Act - Discussed bill. Discussed Medicare site of service payment policy. (no bill #) H.R. 4442,S.2484,CONNECT Act - Sent letter of endorsement. Discussed Medicare coverage and reimbursement of cataract surgery. Labor, Health and Human Services,FY2017 - Lobbied in support of increased funding for CMS' state survey and certification program. (no bill #)

Responded to inquiry regarding in-home supportive services programs. S. 1549, Care Planning Act - Discussed the bill and urged cosponsorship. Discussed structural changes to Medicaid. Discussed health care quality and measurement. Discussed changes to the Medicare benefit design, such as copays, premiums and deductibles. H.R.1571, Improving Access to Medicare Coverage Act - Discussed bill. S.578, Home Health Planning Improvement Act - Discussed bill and urged cosponsorship. Discussed the Medicare Part D prescription drug benefit program and changes needed to lower prescription drug costs and related agency proposed rule changes. S. 1083, H.R.2005 - Discussed legislation to require drug manufacturers to provide rebates for drugs provided to Medicare Part D low-income subsidy beneficiaries, including those who are dually eligible for Medicare and Medicaid. S. 1488, H.R. 2624, Part D Beneficiary Appeals Fairness Act - Discussed bill that would allow seniors to appeal the placement of their medications on a Medicare Part D specialty tier. Discussed Medicare Part D fraud and abuse legislation including lock-in provisions for high risk enrollees. Discussed legislation to require the addition of unique device identifier (UDI) of medical devices in health insurance claim forms. Discussed the Medicare Part B prescription drug demonstration proposal from the Centers for Medicare and Medicaid Services. S. 624, H.R.1220,Removing Barriers to Colorectal Cancer Screening Act - Discussed bill. S. 3040, Labor, Health and Human Services,FY2017 - Lobbied in support of increased funding for CMS' state survey and certification program. S. 1549 - Discussed support of Care Planning Act. Discussed the Medicare Part B prescription drug benefit program and changes needed to lower prescription drug costs and related agency proposed rule changes. H.R. 5122 - Discussed the Medicare Part B prescription drug demonstration proposal. Discussed potential benefit and coverage improvements under Medicare and Medicaid Savings Programs. H.R. 2759, Mental Health Access Improvement Act - Discussed support of bill. Discussed MACRA implementation. Discussed Medicare enrollment and coverage issues such as: provider access, direct billing and penalties. S. 1719, H.R. 3099, RAISE Act - Discussed CMS' efforts regarding family caregiving. Provided feedback on advanced directive registry bill. (no bill #) Discussed independence at home legislation. S. 2961, Compassionate Care Act - Discussed our position and provided feedback. Discussed DOJ investigation regarding Olmstead and ADA violations by South Dakota and provided feedback (DOJ). Responded to inquiry regarding roundtable (ACL). S. 3096, Removing Barriers to Person-Centered Care Act of 2016 - Discussed and provided feedback. Discussed possible hearing witnesses. Discussed Medicaid HCBS spousal impoverishment bill. (no bill #) Responded to inquiry regarding MACRA rules and value modifier. Discussed Medicare's 180-day coverage of skilled nursing facility care. S. 2836, H.R. 5036, Protecting Families with Disabilities Act - Signed letter in support of bill.

S. 709, H.R. 1270, Restoring Access to Medication Act - Supported bill. H.R. 3590, Halt Tax Increases on the Middle Class and Seniors Act - Meetings, calls and emails urging support. Discussed the Fair Medical Billing Act. Discussed Medicare Advantage, Medicare Supplemental and employer health insurance. Discussed Affordable Care Act Medicaid expansion issues, including AARP comments on state 1115 waiver proposals to expand Medicaid. Discussed Medicare-Medicaid integration efforts and financial alignment demonstrations, other CMS demonstration initiatives. Discussed Older Americans Act home and community-based services program funding for FY2017. S. 2956, H.R. 5054 - Discussed nutrition programs including the Supplemental Nutrition Assistance Program (SNAP)and related changes under the 2014 farm bill. S. 3040, H.R. 5926, H.R. 5325, Labor, Health and Human Services Appropriations, FY2017 - Lobbied for funding support for various health and health care related programs serving seniors. S.3111, Seniors Tax Hike Prevention Act - Discussed medical expense deduction for the 65 plus population. Advocated on the issue of limited age rating for private health insurance. S. 3335, H.R. 6043, FAIR Drug Pricing Act - Supported bill.

H.R.6 - Discussed the House Energy and Commerce Committee 21st Century Cures Initiative and Senate HELP Committee efforts focused on drug and medical device innovation issues. S. 31, H.R. 3061 - Discussed the importance of potential savings to both consumers and the federal government of granting Secretarial negotiating authority to the HHS Secretary under Medicare Part D. S. 2019 - Discussed legislation to address pay-for-delay agreements used by drug manufacturers to block lower cost drugs from entering the market. S. 3094, H.R. 5573 - Discussed legislation to reduce the market exclusivity period for biologic drugs. Discussed biologic drug issues including implementation of the new approval pathway for biosimilar drugs. S. 3335, H.R. 6043 - Discussed the need for price transparency on prescription drug prices and comparativeness effectiveness research. Discussed legislation to address the opioid abuse epidemic including fraud and abuse provisions. Discussed opioid issues generally. S. 3056 - Discussed legislation to address abuse of Risk-Evaluation and Mitigation Strategies (REMS) by brand name drug companies to block lower-cost generic drugs from entering the market. S. 3455 - Discussed legislation to allow temporary importation authority in cases of drug shortages and non-competitive markets. S. 2956, H.R. 5054, H.R. 5325, H.R. 2028, Agriculture Appropriations, FY2017 - Lobbied in support of FDA funding. H.R. 6043, FAIR Drug Pricing Act - Supported bill to require manufactures of certain drugs and biological products to report to HHS price increases that result in a 10% or more increase in the price of a drug over a 12 month period.

S. 709, H.R. 1270,Restoring Access to Medication Act - Meetings, calls and emails urging support. H.R. 3590 - Halt Tax Increases on the Middle Class and Seniors Act - Meetings, calls and emails urging support. Discussed the Fair Medical Billing Act. (no bill #) Discussed Medicare Advantage, Medicare Supplemental and employer health insurance. S. 192, Older Americans Act - Discussed reauthorization. Discussed Affordable Care Act Medicaid expansion issues, including AARP comments on state 1115 waiver proposals to expand Medicaid. Discussed Medicare-Medicaid integration efforts and financial alignment demonstrations, other CMS demonstration initiatives. Discussed Older Americans Act home and community-based services program funding for FY2017. S. 2956, H.R. 5054 - Discussed nutrition programs including the Supplemental Nutrition Assistance Program (SNAP)and related changes under the 2014 farm bill. S. 624, H.R.1220, Removing Barriers to Colorectal Cancer Screening Act - Discussed bill. S. 3040, Labor, Health and Human Services Appropriations, FY2017 - Lobbied for funding support for various health and health care related programs serving seniors. (no bill #) S.311, Seniors Tax Hike Prevention Act - Discussed medical expense deduction for the 65 plus population. Advocated on the issue of limited age rating for private health insurance. Advocated on the medical expense tax deduction. Shared comment letters on SNAP with Agriculture Committee staff.

H.R.6 - Discussed the House Energy and Commerce Committee 21st Century Cures Initiative and Senate HELP Committee efforts focused on drug and medical device innovation issues. S. 31, H.R. 3061 - Discussed the importance of potential savings to both consumers and the federal government of granting Secretarial negotiating authority to the HHS Secretary under Medicare Part D. S. 2019 - Discussed legislation to address pay-for-delay agreements used by drug manufacturers to block lower cost drugs from entering the market. S. 3094, H.R. 5573 - Discussed legislation to reduce the market exclusivity period for biologic drugs. Discussed biologic drug issues including implementation of the new approval pathway for biosimilar drugs. S. 3335, H.R. 6043 - Discussed the need for price transparency on prescription drug prices and comparativeness effectiveness research. Discussed legislation to address the opioid abuse epidemic including fraud and abuse provisions. Discussed opioid issues generally. S. 3056 - Discussed legislation to address abuse of Risk-Evaluation and Mitigation Strategies (REMS) by brand name drug companies to block lower-cost generic drugs from entering the market. S. 3455 - Discussed legislation to allow temporary importation authority in cases of drug shortages and non-competitive markets. S. 2956, H.R. 5054, H.R. 5325, Agriculture Appropriations, FY2017 - Lobbied in support of FDA funding. H.R. 6043, FAIR Drug Pricing Act - Supported bill to require manufactures of certain drugs and biological products to report to HHS price increases that result in a 10% or more increase in the price of a drug over a 12 month period.

H.R.6 - Discussed the House Energy and Commerce Committee 21st Century Cures Initiative and Senate HELP Committee efforts focused on drug and medical device innovation issues. S. 31, H.R. 3061 - Discussed the importance of potential savings to both consumers and the federal government of granting Secretarial negotiating authority to the HHS Secretary under Medicare Part D. Discussed legislation to address pay-for-delay agreements used by drug manufacturers to block lower cost drugs from entering the market. S. 3094, H.R. 5573 - Discussed the exclusivity period for biologic drugs. Discussed biologic drug issues including implementation of the new approval pathway for biosimilar drugs. Discussed the need for price transparency on prescription drug prices and comparativeness effectiveness research. Discussed legislation to address the opioid abuse epidemic including fraud and abuse provisions. Discussed opioid issues generally. S. 3056 - Discussed legislation to address abuse of Risk-Evaluation and Mitigation Strategies (REMS) by brand name drug companies to block lower-cost generic drugs from entering the market. S. 1137, H.R. 9, Innovation Act, PATENT Act - Discussed patent reform legislation and related provisions on the Patent and Trademark Office inter partes review (IPR) process and proposed exemptions for brand name drug patents. S. 2956, H.R. 5054, Agriculture Appropriations, FY2017 - Lobbied in support of FDA funding. Responded to inquiry regarding Medicare Part B demonstration.

Responded to inquiry regarding in-home supportive services programs. S. 1549, Care Planning Act - Discussed the bill and urged cosponsorship. Discussed structural changes to Medicaid. Discussed health care quality and measurement. Discussed changes to the Medicare benefit design, such as copays, premiums and deductibles. H.R.1571, Improving Access to Medicare Coverage Act - Discussed bill. S.578, Home Health Planning Improvement Act - Discussed bill and urged cosponsorship. Discussed the Medicare Part D prescription drug benefit program and changes needed to lower prescription drug costs and related agency proposed rule changes. S. 1083, H.R.2005 - Discussed legislation to require drug manufacturers to provide rebates for drugs provided to Medicare Part D low-income subsidy beneficiaries, including those who are dually eligible for Medicare and Medicaid. S. 1488, H.R. 2624, Part D Beneficiary Appeals Fairness Act - Discussed bill that would allow seniors to appeal the placement of their medications on a Medicare Part D specialty tier. Discussed Medicare Part D fraud and abuse legislation including lock-in provisions for high risk enrollees. Discussed legislation to require the addition of unique device identifier (UDI) of medical devices in health insurance claim forms. Discussed the Medicare Part B prescription drug demonstration proposal from the Centers for Medicare and Medicaid Services. S. 624, H.R.1220,Removing Barriers to Colorectal Cancer Screening Act - Discussed bill. S. 3040, Labor, Health and Human Services,FY2017 - Lobbied in support of increased funding for CMS' state survey and certification program. S. 1549 - Discussed support of Care Planning Act. Discussed the Medicare Part B prescription drug benefit program and changes needed to lower prescription drug costs and related agency proposed rule changes. H.R. 5122 - Discussed the Medicare Part B prescription drug demonstration proposal. Discussed potential benefit and coverage improvements under Medicare and Medicaid Savings Programs. H.R. 2759, Mental Health Access Improvement Act - Discussed support of bill. Discussed MACRA implementation. Discussed Medicare enrollment and coverage issues such as: provider access, direct billing and penalties. S. 1719, H.R. 3099, RAISE Act - Discussed CMS' efforts regarding family caregiving. Provided feedback on advanced directive registry bill. (no bill #) Discussed independence at home legislation. S. 2961, Compassionate Care Act - Discussed our position and provided feedback. Discussed DOJ investigation regarding Olmstead and ADA violations by South Dakota and provided feedback (DOJ). Responded to inquiry regarding roundtable (ACL). S. 3096, Removing Barriers to Person-Centered Care Act of 2016 - Discussed and provided feedback. Discussed possible hearing witnesses. Discussed Medicaid HCBS spousal impoverishment bill. (no bill #) Responded to inquiry regarding MACRA rules and value modifier. Discussed Medicare's 180-day coverage of skilled nursing facility care. S. 2836, H.R. 5036, Protecting Families with Disabilities Act - Signed letter in support of bill.

S. 3040, H.R. 5926, H.R. 5325,H.R. 2028, Labor, Health and Human Services Appropriations, FY2017 - Lobbied for funding support for various health and health care related programs serving seniors. S.3111, Seniors Tax Hike Prevention Act - Discussed medical expense deduction for the 65 plus population. Advocated on the issue of limited age rating for private health insurance. S. 3335, H.R. 6043, FAIR Drug Pricing Act - Supported bill. Discussed the Confidence in Long-Term Care Insurance Act (S. 159)/Long-Term Care Insurance Reform Act (H.R. 63) (bill numbers are in the 112th Congress). Discussed ACA repeal, Medicare, and Medicaid.

S. 3040, H.R. 5926, H.R. 5325, H.R. 2028, Labor, Health and Human Services Appropriations bill, FY2017 - Lobbied in support of increased funding for CMS' state survey and certification program. Discussed Medicaid per capita caps and block grants. Discussed DOJ investigation regarding findings of Olmstead and ADA violations by South Dakota. Discussed Olmstead and older adults roundtable and next steps (Administration for Community Living). Discussed arbitration provision in long-term care facility requirements final rule and related issues (no bill, Senate) and discussed final rule in general (CMS webinar). Provided information regarding Medicaid managed long-term services and supports and discussed family caregiver assessment in Medicaid home and community-based services. Discussed impending nursing home closure and resident relocation in the Virgin Islands and related issues. Discussed extension of the Money Follows the Person Rebalancing Demonstration Program. Discussed long-term services and supports financing, Social Security Caregiver Credit Act of 2015 (H.R. 3377), and family caregiving. S. 3504, Creating High-Quality Results and Outcomes Necessary to Improve Chronic (CHRONIC) Care Act - Discussed and provided feedback on draft bill. PL 113-185, Participated in CMS call on the Improving Medicare Post-Acute Care Transformation (IMPACT) Act of 2014. Discussed caregiver-focused health risk assessment in Medicare physician fee schedule final rule. Discussed AARP statement on Medicare physician fee schedule. S. 843, H.R. 1571, Improving Access to Medicare Coverage Act of 2015 - Discussed bill. Discussed health care quality and measurement. Discussed changes to the Medicare benefit design, such as copays, premiums, and deductibles. Discussed MACRA implementation. P.L. 111-148, P.L. 111-152 - Discussed potential repeal of Affordable Care Act. S. 9 - Sent endorsement letter for the Over the Counter Hearing Aid Act of 2016.

S. 709, H.R. 1270, Restoring Access to Medication Act - Supported bill. H.R. 3590, Halt Tax Increases on the Middle Class and Seniors Act - Meetings, calls and emails urging support. Discussed the Fair Medical Billing Act. Discussed Medicare Advantage, Medicare Supplemental and employer health insurance. Discussed Affordable Care Act Medicaid expansion issues, including AARP comments on state 1115 waiver proposals to expand Medicaid. Discussed Medicare-Medicaid integration efforts and financial alignment demonstrations, other CMS demonstration initiatives. Discussed Older Americans Act home and community-based services program funding for FY2017. S. 2956, H.R. 5054 - Discussed nutrition programs including the Supplemental Nutrition Assistance Program (SNAP)and related changes under the 2014 farm bill. S. 3040, H.R. 5926, H.R. 5325, Labor, Health and Human Services Appropriations, FY2017 - Lobbied for funding support for various health and health care related programs serving seniors. S.3111, Seniors Tax Hike Prevention Act - Discussed medical expense deduction for the 65 plus population. Advocated on the issue of limited age rating for private health insurance. S. 3335, H.R. 6043, FAIR Drug Pricing Act - Supported bill.

S. 709, H.R. 1270,Restoring Access to Medication Act - Meetings, calls and emails urging support. H.R. 3590 - Halt Tax Increases on the Middle Class and Seniors Act - Meetings, calls and emails urging support. Discussed the Fair Medical Billing Act. (no bill #) Discussed Medicare Advantage, Medicare Supplemental and employer health insurance. S. 192, Older Americans Act - Discussed reauthorization. Discussed Affordable Care Act Medicaid expansion issues, including AARP comments on state 1115 waiver proposals to expand Medicaid. Discussed Medicare-Medicaid integration efforts and financial alignment demonstrations, other CMS demonstration initiatives. Discussed Older Americans Act home and community-based services program funding for FY2017. S. 2956, H.R. 5054 - Discussed nutrition programs including the Supplemental Nutrition Assistance Program (SNAP)and related changes under the 2014 farm bill. S. 624, H.R.1220, Removing Barriers to Colorectal Cancer Screening Act - Discussed bill. S. 3040, Labor, Health and Human Services Appropriations, FY2017 - Lobbied for funding support for various health and health care related programs serving seniors. (no bill #) S.311, Seniors Tax Hike Prevention Act - Discussed medical expense deduction for the 65 plus population. Advocated on the issue of limited age rating for private health insurance. Advocated on the medical expense tax deduction. Shared comment letters on SNAP with Agriculture Committee staff.

Discussed structural changes to Medicaid. Discussed health care quality and measurement. Discussed changes to the Medicare benefit design, such as copays, premiums and deductibles. S. 1083, H.R.2005 - Discussed legislation to require drug manufacturers to provide rebates for drugs provided to Medicare Part D low-income subsidy beneficiaries, including those who are dually eligible for Medicare and Medicaid. S. 1488, H.R. 2624, Part D Beneficiary Appeals Fairness Act - Discussed bill that would allow seniors to appeal the placement of their medications on a Medicare Part D specialty tier. Discussed Medicare Part D fraud and abuse legislation including lock-in provisions for high risk enrollees. Discussed legislation to require the addition of unique device identifier (UDI) of medical devices in health insurance claim forms. S. 624, H.R.1220, Removing Barriers to Colorectal Cancer Screening Act - Discussed bill. S. 3040, H.R. 5926, H.R. 5325, Labor, Health and Human Services Appropriations bill, FY2017 - Lobbied in support of increased funding for CMS' state survey and certification program. Discussed the Medicare Part D prescription drug benefit program and changes needed to lower prescription drug costs and related agency proposed rule changes. H.R. 5122 - Discussed the Medicare Part B prescription drug demonstration proposal from the Centers for Medicare and Medicaid Services. Discussed potential benefit and coverage improvements under Medicare and Medicare Savings Programs. Discussed Section 1115 Medicaid expansion demonstration waivers (HHS, CMS). H.R. 2759, Mental Health Access Improvement Act - Discussed support of bill. Discussed MACRA implementation. Discussed Medicare enrollment and coverage issues such as: provider access, direct billing and penalties. Discussed DOJ investigation regarding Olmstead and ADA violations by South Dakota (DOJ, ACL) and related public events. Discussed Olmstead enforcement and older adults at roundtable discussion. S. 3096, Removing Barriers to Person-Centered Care Act of 2016 - Discussed and provided feedback. Discussed possible hearing witnesses. Responded to inquiry regarding MACRA rules and value modifier. H.R. 3298, Post Acute Care Value Based Purchasing Act - Discussed and provided feedback. Discussed arbitration provision in LTC facility requirements proposed rule (OMB, CMS, HHS). Responded to inquiry on Virtual Caregiving Fair. PL 111-148 - Discussed ACA Medicaid HCBS spousal impoverishment provisions. Responded to inquiry on state nursing home legislation. Discussed Medicaid assisted living, HCBS setting rule and follow-up (GAO). Discussed Medicare home health (CMS). Urged support for family caregivers in Medicare and Medicaid and testing modeling. Signed letter to CMS regarding arbitration in LTC facility requirements rule. Discussed family caregiver assessment guidance (CMS). Attended PPI home health roundtable with staff from HHS. Responded to a question about a scorecard and letters to CMS. Responded to an inquiry regarding an arbitration regulatory provision. Responded to an inquiry regarding personal needs allowances. Discussed Medicaid functional assessment tools, family caregiver assessment, and follow-up(GAO). Responded to inquiries regarding Medicaid managed long-term services and supports, best practices, and state ombuds programs. S. 3130, Independence at Home Act - Discussed and sent AARP endorsement letter for bill

Responded to inquiry regarding in-home supportive services programs. S. 1549, Care Planning Act - Discussed the bill and urged cosponsorship. Discussed structural changes to Medicaid. Discussed health care quality and measurement. Discussed changes to the Medicare benefit design, such as copays, premiums and deductibles. H.R.1571, Improving Access to Medicare Coverage Act - Discussed bill. S.578, Home Health Planning Improvement Act - Discussed bill and urged cosponsorship. Discussed the Medicare Part D prescription drug benefit program and changes needed to lower prescription drug costs and related agency proposed rule changes. S. 1083, H.R.2005 - Discussed legislation to require drug manufacturers to provide rebates for drugs provided to Medicare Part D low-income subsidy beneficiaries, including those who are dually eligible for Medicare and Medicaid. S. 1488, H.R. 2624, Part D Beneficiary Appeals Fairness Act - Discussed bill that would allow seniors to appeal the placement of their medications on a Medicare Part D specialty tier. Discussed Medicare Part D fraud and abuse legislation including lock-in provisions for high risk enrollees. Discussed legislation to require the addition of unique device identifier (UDI) of medical devices in health insurance claim forms. Discussed the Medicare Part B prescription drug demonstration proposal from the Centers for Medicare and Medicaid Services. S. 624, H.R.1220,Removing Barriers to Colorectal Cancer Screening Act - Discussed bill. S. 3040, Labor, Health and Human Services,FY2017 - Lobbied in support of increased funding for CMS' state survey and certification program. S. 1549 - Discussed support of Care Planning Act. Discussed the Medicare Part B prescription drug benefit program and changes needed to lower prescription drug costs and related agency proposed rule changes. H.R. 5122 - Discussed the Medicare Part B prescription drug demonstration proposal. Discussed potential benefit and coverage improvements under Medicare and Medicaid Savings Programs. H.R. 2759, Mental Health Access Improvement Act - Discussed support of bill. Discussed MACRA implementation. Discussed Medicare enrollment and coverage issues such as: provider access, direct billing and penalties. S. 1719, H.R. 3099, RAISE Act - Discussed CMS' efforts regarding family caregiving. Provided feedback on advanced directive registry bill. (no bill #) Discussed independence at home legislation. S. 2961, Compassionate Care Act - Discussed our position and provided feedback. Discussed DOJ investigation regarding Olmstead and ADA violations by South Dakota and provided feedback (DOJ). Responded to inquiry regarding roundtable (ACL). S. 3096, Removing Barriers to Person-Centered Care Act of 2016 - Discussed and provided feedback. Discussed possible hearing witnesses. Discussed Medicaid HCBS spousal impoverishment bill. (no bill #) Responded to inquiry regarding MACRA rules and value modifier. Discussed Medicare's 180-day coverage of skilled nursing facility care. S. 2836, H.R. 5036, Protecting Families with Disabilities Act - Signed letter in support of bill.

H.R.6 - Discussed the House Energy and Commerce Committee 21st Century Cures Initiative and Senate HELP Committee efforts focused on drug and medical device innovation issues. S. 31, H.R. 3061 - Discussed the importance of potential savings to both consumers and the federal government of granting Secretarial negotiating authority to the HHS Secretary under Medicare Part D. S. 2019 - Discussed legislation to address pay-for-delay agreements used by drug manufacturers to block lower cost drugs from entering the market. S. 3094, H.R. 5573 - Discussed legislation to reduce the market exclusivity period for biologic drugs. Discussed biologic drug issues including implementation of the new approval pathway for biosimilar drugs. S. 3335, H.R. 6043 - Discussed the need for price transparency on prescription drug prices and comparativeness effectiveness research. Discussed legislation to address the opioid abuse epidemic including fraud and abuse provisions. Discussed opioid issues generally. S. 3056 - Discussed legislation to address abuse of Risk-Evaluation and Mitigation Strategies (REMS) by brand name drug companies to block lower-cost generic drugs from entering the market. S. 3455 - Discussed legislation to allow temporary importation authority in cases of drug shortages and non-competitive markets. S. 2956, H.R. 5054, H.R. 5325, Agriculture Appropriations, FY2017 - Lobbied in support of FDA funding. H.R. 6043, FAIR Drug Pricing Act - Supported bill to require manufactures of certain drugs and biological products to report to HHS price increases that result in a 10% or more increase in the price of a drug over a 12 month period.